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Over the past decades, dairy cattle reproduction has presented to farmers with 
several challenges as a consequence of genetic selection for improved milk production 
traits. These challenges include suboptimal postovulatory responses for timed artificial 
insemination synchronization protocols. Another example is the metabolic adjustments 
the preimplantation embryo may undergo in a high producing cow resulting in a high 
likelihood of early embryo loss. Nevertheless, this is an opportunity to study 
alternative options to improve pregnancy rates. Assisted Reproduction Technologies 
(ART) have the potential to solve several issues the modern dairy cow is facing. The 
progress in the practice of ART has been satisfactory over the last two decades and our 
understanding about gametes and embryo biology has substantially improved. Embryo 
transfers using in vitro produced embryos (IVP) might certainly have an advantage 
over conventional breeding methods since ovulation, fertilization and early embryonic 
stages would be bypassed thereby enhancing the likelihood of embryo implantation 
and hence improved conception rates. However, there are several challenges to 
producing good quality embryos in vitro due to difficulties in emulating the natural 
oviduct microenvironments that the preimplantation embryo is experiencing several 
physiological changes en route to the uterus. The objectives of this work were to 
review current literature in regard to mammalian preimplantation embryo production 
in vitro with emphasis in bovine species and to study the effect of metabolic regulators 
(MR) on embryo development as well as using new methods to recover better quality 
sperm especially when using sex-sorted semen. 
  
Chapter Two is an extensive review of the IVP process in mammalian species 
with emphasis on the bovine embryo. Metabolic processes during oocyte in vitro 
maturation, sperm interactions during fertilization and in vitro cultures of different 
preimplantation embryo stages are reviewed. Special attention was devoted to the 
metabolic switch from low to high glucose uptake and metabolism occurring at the 
morula stage. Chapter Three is a systematic study of the effects of conjugated linoleic 
acid (CLA) isomers on embryos produced in vitro. Inclusion of 100 μM CLA- cis 9, 
trans 11 during embryo culture 36 hrs before cryopreservation resulted in embryos 
with higher survival and better developmental rates post-thaw when compared to other 
groups. Chapter Four presents a study about the effect of phenazine ethosulfate (PES) 
and 2, 4-dinitrophenol (DNP) on embryo development at the morula stage to enhance 
glucose uptake and metabolism to improve embryo developmental rates. Combination 
of 0.3 μM PES and 10 μM DNP resulted not only in higher embryo development and 
better quality but also embryos more resistant to cryopreservation procedures. Chapter 
Five describes a study of the effect of four colloidal-based sperm washes (Percoll, Old 
Bovipure, New Bovipure and Androcoll-B) on embryo development and quality. The 
International Embryo Transfer Society regulations strictly indicate that bovine 
embryos produced in vitro should be originated from sperm that has been recovered by 
silane-coated silica particles colloids when fractionation methods are used due to the 
debatable toxic effects of Percoll. Results from these experiments showed that 
embryos derived from sperm recovered by New Bovipure and Androcoll-B achieved 
higher blastocyst rates than Percoll and Old Bovipure groups. In addition, as a follow-
up the effects of MR were evaluated on embryos originated from X-sorted semen. 
Interestingly, PES and DNP supplementation resulted in delayed development and 
poorer morphology in this embryos compared with untreated counterparts. Glucose 
  
uptake threshold may be lower in female embryos and/or they may have a different 
substrate preference as compared to male embryos.  
Our contribution to science may provide information for a better understanding 
of IVP and help shape the direction of future research. More importantly, it may 
provide the basis for production of better quality embryos originated from gender-
selected semen with more chance of survival to term, thereby improving conception 
rates in dairy cattle. 
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CHAPTER ONE: INTRODUCTION 
 Livestock species are a very important source of food around the world. Over 
the last several decades, dairy cattle reproductive performance has gradually declined 
as genetic selection for milk traits has improved milk production (Butler, 2003). The 
modern dairy cow faces several challenges throughout her lifetime. From the moment 
of conception to preparturition, the presumptive embryo/fetus is constantly adapting to 
the uterine environment that is inherently related to the dam’s metabolic status, 
especially toward the end of gestation (Bell, 1995). Moreover, a critical physiological 
stage for a cow is the transition period occurring three weeks pre- and three weeks 
post partum. Two important events occur at this stage: fetal overcrowding of the 
rumen in addition to the homeorhetic changes to accommodate the rather stressful 
lactation nutrient requirements postpartum. Suboptimal management during this 
physiological stage may result in retained placentas, subsequent poor reproductive 
performance and it seems that offspring performance could be also affected by this 
stressful situation.  
An optimal maternal environment would provide the right nutrients/factors that 
will be reflected in the offspring’s future performance under appropriate management 
conditions from birth throughout her entire lifetime (Absalón-Medina et al., 2009). 
Poor synchronization responses for timed artificial insemination, early pregnancy 
losses due to milk production stress, and suboptimal management conditions may 
constitute a large economic challenge for dairy producers (Sartori et al., 2010). For 
that reason, assisted reproduction technologies (ART) such as in vitro embryo 
production would provide the opportunity to farmers to bypass the aforementioned 
two critical steps thereby improving conception rates (Vasconcelos et al., 2006; 
Demetrio et al., 2007). Furthermore, ART have the potential to improve not only 
pregnancy rates, but also may provide producers opportunities to intelligently allocate 
2 
types of genetics and gender specificity in order to improve their current management 
programs for a likely increased demand of livestock products. 
 In vitro embryo production has evolved satisfactorily throughout the past three 
decades (reviewed in Chapter Two). Studies on murine and ruminant species have 
provided substantial knowledge about the different microenvironments the 
preimplantation embryo should experience for optimal development and for successful 
pregnancies. In addition, striking findings on the biology of oocyte maturation have 
unveiled critical factors, and the requirement for bidirectional communication with 
cumulus cells, to guarantee an optimal meiotic progress during this time in 
development (Gilchrist, 2011). In Chapter Two, we extensively review in vitro 
embryo production covering in vitro maturation, fertilization and the culture of 
preimplantation embryos throughout their different stages. Although there have been 
improvements in the protocols for production of embryos in vitro, there are still 
challenges that embryologists and clinicians face, such as the tradeoff between using 
defined media and media supplemented with serum; both approaches may result in 
negative outcomes but for different reasons. For example, defined media lack 
embryotrophic factors that are normally present in serum and serum-supplemented 
media may contain high levels of triglycerides and fatty acids that are detrimental to 
embryos. However, there are polyunsaturated fatty acids that reportedly become 
incorporated into cell membranes and provide membrane protection especially for 
embryos undergoing cryopreservation procedures (Pereira et al., 2008). Conjugated 
linoleic fatty acids (CLA) have been shown to act as signaling factors by regulation of 
fatty acid synthesis. A systematic study of the effects of CLA isomers during in vitro 
embryo production and cryopreservation procedures is described in Chapter Three. 
 Another subject of interest during preimplantation embryo culture is the 
regulation of glucose metabolism at the morula stage (Thompson et al., 2000; De La 
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Torre-Sanchez et al., 2006). Soon after fertilization, in vivo embryo development 
depends mostly on tricarboxylic acids such as pyruvate and lactate as sources of 
energy before reaching the morula stage. Coincident with the entrance to the hypoxic 
environment of the uterus, hexokinase activity is unregulated in order to allow more 
glucose uptake by the embryo for metabolism mainly via glycolysis and the pentose 
phosphate pathways. However, in vitro, this metabolic switch is not always activated 
in a pool of embryos and subsequently their development becomes arrested due to the 
inability to enhance glucose consumption and to meet the rapidly increasing energy 
requirements. Nonetheless, there are metabolic regulators that act as enhancers of 
glucose metabolism via the aforementioned pathways, thereby rescuing the pool of 
embryos that would otherwise fail. In Chapter Four we present our work on metabolic 
regulators provided at morula stage with the novel contribution of PES and DNP in 
combination to target simultaneously the two different metabolic pathways mentioned 
previously.  
 An important area during in vitro embryo production is the handling and 
processing of the semen. According to the International Embryo Transfer Society 
(IETS), semen has to be processed with colloidal solutions free of 
polyvinylpyrrolidone (PVP) since sperm toxicity has been reported when PVP is part 
of the colloid. Alternative macromolecules such as silane-coated silica particles have 
been recommended and approved by the IETS. In addition, these macromolecules 
have been reported to allow recovery of better quality sperm by close matching to 
their iso-pynic point (Morrell and Rodriguez-Martinez, 2010). In an effort to replace 
our Percoll (containing PVP) sperm fractionation procedures, we tested two different 
colloidal solutions containing silane-coated silica particles to measure their effect on 
computerized sperm motility parameters, fertilization rates and overall embryo 
development and quality (Chapter Five). Further, sex-sorted semen in vitro 
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fertilization (IVF) is a relatively new procedure that has the potential to provide 
several advantages to the livestock industry over conventional methods, especially for 
dairy cattle (Xu et al., 2009). For example, genetic improvements are expected to 
occur at a more rapid pace with enhanced efficiency of genetic selection of female 
replacements. Therefore, producers might reduce replacement heifer stocks and/or sell 
more heifers, which in turn could improve profitability. However, sex-sorted semen 
IVF to produce embryos of a desired gender is a new procedure, hitherto lacking a 
standard protocol. It is complicated because sires have different sperm-sorting and 
freezability threshold; thus, the sperm quality varies even more than when using 
conventional methods. As a result, IVF protocols that may work for one specific bull 
may not work for another (Xu et al., 2009). Another important area that may 
undoubtedly be inherent to sex-sorted semen IVF research is the development of 
media for embryos of a specific gender. It has been reported that there is a sex-based 
nutrient/substrate preference in embryos (Garcia-Herreros et al., 2012; Sturmey et al., 
2009). Collectively, alternative colloidal-based sperm separators that would improve 
the efficiency of recovering good quality sperm, and thus better embryo development, 
along with addition of metabolic regulators to improve glucose consumption of 
embryos of a desired gender, were the objectives of our last experiments presented in 
Chapter Five. 
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ABSTRACT 
Despite advantages of in vitro embryo production in many species, widespread 
use of this technology is limited by generally lower developmental competence of in 
vitro derived embryos compared to in vivo counterparts. Regardless, in vivo or in vitro 
gametes and embryos face and must adjust to multiple microenvironments especially 
at preimplantation stages. Moreover, the ideal embryo has to be able to further adapt 
to environmental cues in utero to result in the birth of live and healthy offspring. 
Enormous strides have been made in understanding and meeting stage-specific 
requirements of preimplantation embryos, but interpretation of the data is more 
difficult due to the complexity of the wide array of culture systems and the remarkable 
plasticity of developing embryos that seem able to develop satisfactorily under a 
variety of conditions. Nevertheless, the objective remains meeting, as closely as 
possible, the preimplantation embryo requirements as it occurs in vivo. In general, 
oocytes and embryos develop more satisfactorily when cultured in groups. However, 
optimization of individual culture of oocytes and embryos is an important goal and 
area of intensive current research that will allow avoidance of ovarian 
superstimulation, with physiological and psychological advantages for patients. This 
review includes stage specific embryo requirements, culture systems including in vitro 
maturation, in vitro fertilization or intracytoplasmic sperm injection, and in vitro 
embryo culture, with a view to optimizing embryo culture in general, and culture of 
single embryos in particular.  
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INTRODUCTION 
Genetic selection is constant and the main factor responsible for altering the 
genome of most species including humans. In domestic species, iatrogenic selection 
for desired traits has inadvertently resulted in an increased homozygosity stemming 
from the loss of variation in the chromosomal region flanking the selected allele and it 
is defined as selective sweeps (Ramey et al., 2013). As an example, dairy cattle 
reproduction decline has been related to genetic selection for improved milk 
production traits (Butler, 2003). One solution to overcome this issue is by using novel 
techniques offered in the field of assisted reproduction technologies. 
The ultimate goal of assisted reproductive technologies (ART) is the birth of 
healthy offspring. Despite rapid progress in the field of ART for both human and 
veterinary medicine, several challenges remain. One example is that defined media 
still do not reflect the natural microenvironments of the female reproductive tract 
where gametes interact and embryos develop. Therefore, further optimization of 
culture conditions would provide a better environment especially for single oocytes, 
thereby circumventing problems associated with ovarian super stimulation and transfer 
of multiple embryos.  
Defining optimal factors and substrates for the entire in vitro embryo 
production process has been an area of intensive research leading to understanding 
those most critical for early preimplantation embryonic development. However, the 
dynamic and complex nature of in vivo conditions makes it difficult to emulate such 
microenvironments in vitro with defined media. Complicating our assessment of 
culture methods is the plasticity of gametes and preimplantation embryos, with 
10 
acceptable development reported for a wide variety of culture conditions. Nonetheless, 
there are opportunities to define better culture systems that more closely match the 
physical and chemical interactions between gametes and embryos with the diverse 
microenvironments presented by the female reproductive tract. Improvements in 
culture systems should be focused on embryo metabolism at every stage of in vitro 
embryo production (IVP). In vivo, the embryo is exposed to a dynamic environment as 
its metabolic needs evolve from early to later preimplantation stages. Consumption of 
sodium pyruvate and other carboxylic acids is relatively greater at precompaction 
stages, coincident with the relatively more oxygenated environment of the oviduct. 
Once in the uterus, usually at compacted morula or early blastocyst stages, the oxygen 
tension is decreased and glucose metabolism increases to accommodate higher energy 
demands. This switch from low to high glucose consumption occurs in most species 
(Thompson et al., 2000; Gardner et al., 2013) and has become an important area for 
research in vitro. More optimal IVP systems would result in fewer “developmental 
block” issues and facilitate production of more high quality embryos for successful 
fresh-transfers or cryopreservation. 
Here we review current understanding of optimal conditions for oocyte 
maturation (IVM), in vitro fertilization (IVF) or intracytoplasmic sperm injection 
(ICSI) and with more emphasis on in vitro embryo culture, pointing out existing 
obstacles and promising avenues of research for improvement. Our intention is to 
provide a comparative review of current knowledge of bovine and other non-human 
mammalian IVP models as a reference for potential application to human ART. 
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IN VITRO MATURATION 
In vitro maturation in human ART is mostly used as a last resort, especially 
when patients do not respond well to superstimulation protocols; the resulting low 
maturation rates or overall poor developmental competence may potentially be 
inherent to the intrinsic quality of the oocyte and not due to the IVM procedure per se. 
Consequently, the poor IVM results have raised concerns and thus have limited the 
use of this procedure in human medicine (Banwell and Thompson, 2008; Smitz et al., 
2011). In addition, the ICSI technique further limits the application of IVM for human 
oocytes since the first steps prior to and during fertilization are bypassed by the ICSI 
procedure. However, IVM may be suitable for patients with polycystic ovarian 
syndrome who are at higher risk of developing ovarian hyperstimulation syndrome 
when they undergo follicle superstimulation treatments (Banwell and Thompson, 
2008).  
There has been considerable progress in refining protocols for in vitro 
maturation of oocytes of livestock species with potential application to human IVM 
(Banwell and Thompson, 2008; Gilchrist, 2011). Controlling the delay of meiotic 
progress by means of adenylate cyclase activators, cyclic adenosine monophosphate 
(cAMP) analogues, or phosphodiesterase inhibitors is very critical during IVM. In 
addition, optimal conditions for cumulus cells surrounding the oocyte need to be 
considered as there is a complex, yet well orchestrated, bi-directional communication 
between these two cell types. Oocyte-secreted factors (OSF; Gilchrist, 2011) are 
involved in cumulus cell pathways that are directly related to the oocyte’s welfare i.e. 
regulation of apoptosis, metabolism, proliferation, expansion and differentiation. 
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Recently, natriuretic peptide type C (NPPC) and its receptor (NPR2) were reported as 
essential for the maintenance of meiotic arrest in mouse oocytes (Zhang et al., 2011). 
The proposed mechanism in vitro is through production of cyclic guanosine 
monophosphate (cGMP) by exogenous NPPC binding to its receptor on cumulus cells. 
Consequently, cGMP is transferred, through gap junctions, to the oocyte where it 
plays a role in the inhibition of the phosphodiesterase 3A (PDE3A), thereby 
maintaining meiotic arrest by protecting cAMP levels from the degrading effects of 
active PDE3A. In vitro, exogenous estrogen seems to be required for the maintenance 
of NPR2 (Zhang et al., 2011). Collectively, cAMP and cGMP modulators along with 
OSF may result in improved protocols for in vitro maturation with potential 
application for ART.  
During maturation, migration of mitochondria and lipid droplets to the center 
of the oocyte and location of cortical granules beneath the oolemma are good 
indicators of oocyte competence (Gordon, 2003). The novel maternal effect gene, 
peptidylarginine deiminase 6 (PADI6), which appears to be restricted in the mouse to 
the oocyte and early embryo, is required for the formation of cytoplasmic lattices and 
directly related to the formation of microtubules (Kan et al., 2010). The latter are 
responsible for the microorganelle redistribution during maturation and, thus, it is 
worthwhile to characterize this pathway to optimize IVM approaches. Since PADI6 is 
a Ca2+ sensitive enzyme, the role of Ca2+ oscillations is relevant in PADI6 function 
during maturation/fertilization (Malcuit et al., 2006). 
Better non-invasive markers and improved ways to determine oocyte quality 
are needed, since morphological assessment is still the method of choice to select 
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“good” quality oocytes. As discussed by Goovaerts et al. (2010), new quality 
assessment protocols should meet specific criteria such as being practical, fast, and 
most importantly, reliable. Brilliant cresyl blue (BCB) has been reported as a good 
option for non-invasive assessment of oocyte and zygote quality (Koester et al., 2011). 
Although Goovaerts et al. (2010) detected no differences between control oocytes 
selected morphologically and BCB positive oocytes, a more recent report using BCB 
found that developmentally competent oocytes/zygotes exhibited lower zonar 
birefringence intensity parameters by polarized light microscopy (Koester et al., 
2011).  
The potential for providing an assisted metabolism to oocytes that have been 
exposed to a sub-optimal in vivo environment is a promising area for research. An 
altered follicular environment may result in changes in glucose metabolism (Sutton-
McDowall et al., 2010) that profoundly affect viability of cumulus oocyte complexes 
during maturation. In cases of hyperglycemia, enzymes related to glycolysis such as 
hexokinase may become saturated and glucose may be repartitioned to other pathways 
such as the hexosamine biosynthesis (HBP [fuel sensing]) or Polyol pathways. 
Consequently, imbalances to the redox system may occur as well as undesirable O-
linked glycosylation of serines and threonines normally responsive to kinases for 
activating other necessary pathways in meiotic progression (Sutton-McDowall et al., 
2010). Nitration of these same amino acids might also be more common in an 
ammoniagenic environment (Lei et al., 2007) resulting from diets (e.g. ruminants) or 
media high in amino acids, thus, oocyte and embryonic developmental competence 
would be compromised.  
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Cumulus-oocyte complexes cultured in media supplemented with serum 
usually perform better than those cultured in serum-free media supplemented with 
synthetic macromolecules. However, in some situations, serum from patients (e.g. 
patients with recurrent pregnancy loss or contaminated commercial batches) may 
contain undesirable components that could potentially be detrimental for IVM. 
Evidence of rescuing factors, such as paraoxonase 1 (PON1 [in oocytes]) and 
preimplantation factor (PIF [in embryos]), suggests that oocytes may be improved by 
an optimal redox environment and thus increase the chances of fertilization or 
subsequent embryo development (Browne et al., 2008; Stamatkin et al., 2011a). 
Further research on these various factors is needed to better characterize under which 
conditions they might be beneficial as supplements for IVM. In addition, metabolic 
pathways in vitro are regulated by substrate availability in media and gas phase 
conditions (Banwell and Thompson, 2008; Bermejo-Alvarez et al., 2010). Exploring 
the latter options may result in optimization of IVM for a specific case when standard 
IVM conditions do not work due to a metabolic enzyme alteration. 
IN VITRO FERTILIZATION/INTRACYTOPLASMIC SPERM INJECTION 
Under natural conditions sperm travel through the utero-tubal junction to the 
isthmic region of the oviduct which acts as a functional sperm reservoir. Binder of 
sperm proteins, type 1, 3 and 5, (BSP; previously known as bovine seminal plasma 
proteins) have an active role in the binding of the sperm to the tubal epithelium and 
the release thereof during ovulation in order to target the matured egg (Gwathmey et 
al., 2006; Hung and Suarez, 2012). In addition, BSP proteins (BSP1 in particular) play 
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a role in sperm membrane configuration including removal of cholesterol and 
phospholipids during capacitation (Gordon, 2003; Gwathmey et al., 2003). In the 
isthmus, sperm bound to the luminal epithelium enjoy prolonged viability before 
undergoing capacitation and hyperactivation prior to fertilization (Gordon, 2003; 
Suarez, 2008). Although unknown, capacitation and hyperactivation have been 
thought of occurring simultaneously in vivo, however, different pathways for these 
processes have been demonstrated in vitro (Marquez and Suarez, 2004). In order to 
become capacitated (acrosome responsive), sperm have to undergo protein tyrosine 
phosphorylation via a cAMP/PKA signaling pathway. Hyperactivation is mediated by 
a Ca2+ signaling pathway.  
Early fertilization events have been widely characterized in several species. 
Once the sperm is in the cytoplasm, the MII oocyte releases its cortical granule 
contents into the perivitelline space to avoid polyspermy. In addition, decondensation 
of the sperm head (replacement of protamines by maternal histone and non-histone 
proteins) takes place until the male pronucleus and pronuclear envelope are formed. 
Release of a spermatic phospholipase Cζ (PLCζ) is needed for the hydrolysis of 
oocyte-cytoplasmic phosphatidylinositol-4, 5-bisphosphate (PIP2) with formation of 
diacyl-glycerol phosphate (DAG) and inositol 1,4,5-tris-phosphate (IP3). Subsequently 
these products stimulate resumption of meiosis by the arrested MII oocyte and 
extrusion of the second polar body followed by formation of female pronuclear 
envelope and pronucleus. This series of events depends on Ca2+ oscillations originated 
by sperm PLCζ that take place within a few hours after the spermatozoon enters the 
ooplasm. These oscillations are essential and result in downstream production of 
16 
molecules necessary for MII oocyte activation (reviewed in Kurokawa et al., 2004; 
Malcuit et al., 2006; Ducibella and Fissore, 2008). However, alternative mechanisms 
involved during oocyte activation seem to show a certain degree of redundancy. One 
example is the sperm-borne protein with conserved AA sequence throughout species, 
post-acrosomal WW domain binding protein (PAWP), that induces MII oocyte 
activation in a Ca2+ oscillation-related manner (Aarabi et al., 2010). Further, it has 
been shown that not only Ca2+ oscillations are needed for the progression of the cell 
cycle, but also zinc “sparks”, a conserved mammalian mechanism, are required early 
after fertilization/activation (Kim et al., 2011). Collective integration of MII oocyte 
activation processes may need to be addressed. 
Concerns about O2 tension and its inherent relationship with the redox system 
have not only been the subject of investigation during IVM, but also at IVF. Studies 
by Lopes et al. (2010) and Bain et al. (2011) indicate a positive effect of higher O2 
tension during the first cellular cycle post IVF. In addition, overuse of antioxidants 
during bovine IVF impaired sperm quality, normal pronuclear formation, and embryo 
development to the blastocyst stage (Gonçalves et al., 2010; Marques et al., 2010). 
Thus, reactive oxygen species (ROS) may be critical for successful IVF, especially 
during the first cell cycle and therefore antioxidants and ROS scavengers should be 
used very judiciously (Lopes et al., 2010). 
The technique of intracytoplasmic sperm injection (ICSI) is nearly unique as a 
means to achieve fertilization in the face of severe male infertility-related conditions 
(Merchant et al., 2011). Although ICSI is the most widely used technique for micro-
assisted fertilization in humans, it remains inefficient for most other species due to 
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issues related to initiation of the normal cascade of events associated with activation of 
the arrested MII oocyte. 
Over the last few years, several studies for improvements of ICSI in livestock 
have been conducted. The ICSI procedure has been used as an option to improve 
embryo rates in livestock species where IVF systems are currently inefficient (e.g. 
equine IVF). As reviewed by García Roselló et al. (2009), the future of ICSI, in 
laboratory and livestock species, will most likely deal with problems not associated 
with male infertility. Nevertheless, this will provide an excellent opportunity for 
refinement of protocols to optimize the technique. Malcuit et al. (2006), working with 
cattle, indicated that some of the signaling mechanisms that lead to the activation of 
the phosphoinositide pathway and generation of Ca2+ oscillations during natural 
fertilization were not replicated by ICSI. The problem appeared to stem from the 
inability to induce Ca2+ oscillations and that activation by an exogenous agent was 
required to initiate embryo development. Several methods for exogenous activation 
after ICSI have been reported such as applying calcium ionophores (e.g. ionomycin) in 
combination with 6-DMAP (Pereyra-Bonnet et al., 2008), ethanol (Abdalla et al., 
2009), and roscovitine plus cytochalasin B (Devito et al., 2010). To date, global non-
human blastocyst rate from ICSI remains at approximately 20 %. 
Sperm selection based on physiological processes with potential practical 
applications have been reported (Morrell and Rodriguez-Martinez, 2010) where single 
layer centrifugation (SLC) and hyaluronan binding assays (HBA) are becoming the 
method of choice. Laser technology might be used to further improve ICSI, especially 
for livestock species as a model for potential human application. Recently, a real time 
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system was developed using laser technology and fluorescent imaging to measure 
individual sperm performance efficiently (Shi et al., 2011). This system offers an 
advantage for sperm selection since it allows measurement of mitochondrial 
membrane potential. Thus, studies of sperm energetics could be performed to 
characterize individual sperm not only from valuable high genetic merit animals and 
endangered species, but also from human patients being referred for IVF services. A 
possibility of improving ICSI results, at least in livestock species, may be to use this 
technology after the swim-up method to further optimize sperm selection from the 
pool of elite quality sperm (M.W. Berns, personal communication). Therefore, 
development of better approaches is needed to guarantee that the fertilizing 
spermatozoon expresses optimum performance i.e. capable of undergoing acrosome 
responsiveness, hyperactivation, and activation of the arrested MII oocyte. Along 
these lines, alternative options for oocyte activation after ICSI may need to be 
addressed such as the use of PLCζ or PAWP to trigger the necessary, more natural, 
Ca2+ oscillations or zinc sparks. Cloning research in livestock species may also be 
directly benefited by such studies.  
EMBRYO CULTURE SYSTEMS 
The existence of diverse embryo culture media and methods has made 
definition of the optimal components of embryo culture media very challenging. In 
vivo, the embryo is exposed to a dynamic environment as its metabolic needs evolve 
from early to later preimplantation stages. However, despite greater understanding of 
the biology of the embryo and its interaction with the oviduct and uterus, it has been 
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very difficult to emulate the different stage-regulated embryo metabolic pathways in 
vitro. Soon after fertilization the embryo benefits from a well oxygenated environment 
as in the oviduct and it shows substrate preference for tricarboxylic acids such as 
pyruvate and lactate. However, as the embryo develops to morula there is a metabolic 
switch that needs to be activated to supply an alternative source of energy in response 
to a more hypoxic environment in the uterus.  
Emerging new technologies such as microfluidics, time-lapse cinematography 
and metabolomics may provide further advances in for producing good quality 
embryos in vitro before transfer to improve the likelihood of successful pregnancies 
and also to reduce the number of embryos transferred per cycle. 
Preimplantation embryo metabolism and in vitro environment 
Pioneering in vitro work by Yanagimachi and Chang (1964) on murine species 
led to important milestones in the creation of mammalian embryo culture media. From 
the 70’s onwards, using murine models, findings of Bavister and coworkers resulted in 
major advances toward meeting embryo metabolic requirements (Bavister et al., 
1983). During this time, Tervit and coworkers also made important progress on in 
vitro embryo culture by developing a synthetic oviduct fluid (SOF) medium based on 
biochemistry and physiology studies of the ovine oviduct (Tervit et al., 1972; Tervit et 
al., 1974). In addition, studies by Ménézo et al. (1976) provided insight on human in 
vitro embryo development. Critical work by Biggers and coworkers in the 80s and 
90s, using mouse models and other mammalian species, created a sequential simplex 
optimization media (SOM), and later improvements (KSOM) allowed the 2-cell block 
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to be overcome at last (Lawitts and Biggers, 1991; Summers et al., 1995). Studies by 
Gardner and collaborators during this time led to important findings on embryo 
metabolism and creation of Gardner’s media (Gardner et al., 1994). Furthermore, 
research work on livestock species resulted in critical improvements or development 
of new media such as Ménézo’s B2 (Ménézo et al., 1984), CR1aa (Rosenkrans et al., 
1993) and SOFaa (Holm et al., 1999). The most important milestones in development 
of modern embryo culture media are summarized in Table 1. 
The extensive research activity carried on from ~1970-2000 was the basis of 
today’s commercial media formulations for human and other mammalian species, but 
many of the advances in culture systems have been the result of empirical adjustments. 
As the embryo migrates from the oviduct to the uterus, a metabolic switch from low 
glucose to high glucose consumption occurs in most species (Thompson, 2000; 
Harvey, 2007; Feugang et al., 2009 [vide Figure 1]). Interestingly, equine embryos 
seem to show a different pattern in substrate preferences throughout preimplantation 
development, preferring hyperglycemic (>15 mM) and hypoxic conditions (5% CO2, 
5% O2 [Hinrichs, 2010]). In any species, media formulation should account for this 
switch in metabolic pathways to most efficiently produce ATP depending on embryo-
stage preference. Various chemical modulators and nutrients with established 
metabolic effects for optimizing embryo development are listed in Table 2. Further 
description of these metabolic effects is provided in the remainder of this section. 
Oxidative metabolism is the main source for ATP especially at early 
(precompaction) embryonic stages, sodium pyruvate being the preferred tricarboxylic 
acid substrate. One of the earlier problems faced by researchers was the effect of 
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glucose in media at precompaction stages and the attendant undesirable early onset of 
glycolysis resulting in embryo growth retardation or embryo development block 
(reviewed by Thompson, 2000). However, supplementation of culture media with 
ethylenediaminetetraacetic acid (EDTA) overcame this issue with its inherent 
“Crabtree-effect” allowing embryos to continue further cell cycles (Thompson et al., 
2000; Ménézo et al., 2013). After the problem of preventing early onset of glycolysis 
was solved by the addition of EDTA, attention turned to enhancement of glucose 
metabolism at postcompaction stages. Compounds with the opposite effect of EDTA 
not only enhance glucose consumption, but improve embryonic development and 
competence. Oxidative phosphorylation uncouplers such as 2, 4 dinitrophenol (DNP) 
partially inhibit oxidative phosphorylation while enhancing glycolysis (Thompson et 
al., 2000). Another metabolic regulator, phenazine ethosulfate (PES), is an electron 
acceptor for reduced nicotinamide adenine dinucleotide phosphate (NADPH) thereby 
enhancing the pentose phosphate pathway (De La Torre Sanchez et al., 2006). In 
addition, PES inhibits fatty acid synthesis (Sudano et al., 2011). Since DNP and PES 
both favor the metabolism of glucose, but via two different metabolic pathways, it 
would be of interest to evaluate the effects on the redox status of combining both 
chemicals under different glucose supplementation levels. Since these metabolic 
regulators may play a role in the fatty acid metabolism, the idea of combining their use 
with polyunsaturated fatty acid (PUFA) is also attractive.  
Assisted metabolism may be necessary to aid in the regulation of glucose 
uptake in postcompaction in vitro produced embryos. This approach would permit 
improved efficiency of ATP production by competent embryos while also rescuing 
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embryos that would otherwise fail. Along these lines, Lopes et al. (2007) reported 
bovine embryo competence in relation to expression of glucose transporter 1 (GLUT-
1) and glucose-6-phosphate dehydrogenase (G6PD) mRNAs. They demonstrated that 
metabolically active blastocysts use more oxygen and glucose than less competent 
embryos, indicating greater capability for glycolysis. Further, Leese et al. (2008) 
reported a functional metabolic “quietness” of viable preimplantation embryos, in 
contrast to impaired embryos which demonstrated increased energy consumption. 
Thus, there is a differential threshold between embryos with a certain degree of 
impairment showing higher (altered) metabolic rates and “quiet” embryos with an 
optimal degree of metabolic activity. Relevance of glucose transporters becomes 
critical, as embryo compaction occurs and glucose metabolism is enhanced, coincident 
with expression of insulin and IGF-I receptors. These receptors act in concert with 
glucose transporters, especially GLT-8, an insulin sensitive GLUT (reviewed by 
Purcell and Moley, 2009). According to a recent report, male and female bovine 
embryos have different requirements for glucose. Male embryos showed higher 
developmental rates compared to female embryos due, at least in part, to a higher 
metabolic rate of glucose (Garcia-Herreros et al., 2012; Table 2). This finding could 
significantly impact media formulation especially for the dairy or beef industry where 
the markets for female or male embryos are more popular, respectively.  
Oxygen tension plays an important role in the expression of hypoxia inducible 
factors required for the up regulation of genes involved in the process of enhanced 
glucose metabolism and overall embryonic developmental competence 
postcompaction (Harvey, 2007). Today’s embryo culture systems rely on a controlled 
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oxygen tension of 5-10% because there is extensive evidence for detrimental effects of 
higher oxygen tension in culture without supplementation of antioxidants or co-culture 
with somatic cells. Even the slightest increase in oxygen tension above the 
aforementioned range resulted in embryos with higher rates of apoptosis (among other 
developmental variables) than those cultured under controlled hypoxic conditions (5% 
O2; Arias et al., 2012).  
Amino acid (AA) metabolism is gaining research interest in human and bovine 
species. Current sequential IVC systems provide the usual non-essential AAs during 
precompaction stages and a full array of essential and non-essential AAs at peri and 
postcompaction stages (reviewed by Gardner, 2008 and Feugang et al., 2009). 
Although providing an array of AA supports preimplantation embryo development, 
there has not been extensive research on the AA requirements at specific embryo 
stages. Besides the knowledge that alanine and glycine are the two major AAs 
required in higher concentrations for IVC, methionine is emerging as also being 
critical due to its interaction with folate (Kwong et al., 2010). The interaction of 
folate/methionine metabolism seems especially important because methionine is 
present in supraphysiological concentrations in contemporary culture media 
formulations, whereas, folate is not present in most IVC media formulations. The 
implications are that the embryo may deplete folate stores from the oocyte during 
advanced embryonic cellular cycles resulting in potential interruptions in metabolism. 
This adverse situation may be exacerbated with an excess of methionine available for 
intracellular trans-methylation and possible epigenetic alterations (Kwong et al., 
2010). However, Bonilla et al. (2011) reported that DNA methylation of blastocyst 
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nuclei was unaffected by methionine concentration at several concentrations in vitro. 
In addition, the authors determined that methionine requirement during bovine 
preimplantation development is between 14-21 μmol/l and similar to the 
concentrations found in the bovine reproductive tract. The interaction of methionine 
and folate needs to be considered further. 
Embryos of ruminants, as well as other mammals have requirements for both 
essential and non-essential AAs. Besides methionine, the essential AA lysine 
participates in metabolic pathways (e.g. donating carbon skeletons) and more 
importantly can be an epigenetic target site in histone tails to modulate chromatin 
structure (Monteiro et al., 2010). Another essential AA is histidine, which seems to be 
related to interferon tau expression (IFNτ; embryonic antiluteolytic cytokine required 
and secreted in ruminants for maternal recognition of pregnancy; Groebner et al., 
2011). In addition to increased requirements for essential AAs as embryo development 
progresses,  AA preference by gender has been reported recently. In vitro produced 
female embryos showed preference for arginine, glutamate and methionine whereas 
male embryos showed preference for phenylalanine, tyrosine and valine (Sturmey et 
al., 2010). For these reasons AA embryo requirements in vitro need to be established 
for improved development and conception rates per species. 
According to metabolic and nutritional needs, the mammalian embryo shows a 
marked difference in requirements at early and late preimplantation stages. For this 
reason, sequential media have proved successful as extensively addressed by Gordon, 
2003 and reviewed by Thompson, 2000; Gardner, 2008; Feugang et al., 2009; Hasler, 
2010. Different sequential media formulations have been reported to achieve 
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acceptable rates of embryo development in vitro; however, there is usually limited 
information available on success rate following embryo transfer. Sequential culture 
strategies consider at least two phases covering pre-and-postcompaction stages, but, as 
discussed by Gruber et al. (2011), there remains much controversy regarding 
sequential vs. one-step culture with both similar and contradictory results. 
The success of an IVP laboratory may stem not only from improvements of the 
IVC per se, but from the entire IVP system (Gardner, 2008). The latter includes: 
incubation conditions, gas phase, culture media, oil overlay, tissue culture 
ware/contact supplies, and embryo density and the volume of medium. In addition, 
embryologist or technician skills have to be considered as part of the system. One 
important area that deserves more attention is pH regulation in livestock embryo 
culture media. Emulation of physiological pH at the different preimplantation embryo 
stages may be critical for optimizing single and overall embryo culture systems. 
Therefore, the use of new pH zwitterionic buffering systems that would maintain a 
desired pH with minimal variations, during culture or handling, could result in more 
suitable environments for improved embryo development (Swain, 2010).  
Defined media and supplements improving embryo production 
Over the past 20 years a marked evolution in IVP systems has occurred from 
using surrogate xeno-oviducts and embryo co-culture conditions with somatic cells 
toward the optimum goal of producing embryos in defined serum-free media (Gordon, 
2003; Hasler, 2010; Momozawa and Fukuda, 2011; Lazzari et al., 2011). The use of 
serum was the basis for the development of culture systems that did not require co-
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culture conditions. Although supplementation of IVC media with serum or albumin is 
widely acknowledged to support improved embryo development relative to serum-free 
conditions, these supplements may also include detrimental factors that potentially 
impair embryo development. When using serum-containing media, a problem is 
encountered in culturing embryos destined to undergo cryopreservation procedures. 
Excessive accumulation of triglycerides may occur that results in detrimental effects 
on post-thaw performance. However, a recent study on mitochondrial ultrastructure 
assessed by transmission electron microscopy indicated no differences between 
embryos treated with serum vs. serum-free groups suggesting that serum may not be a 
major detrimental factor at least at the mitochondrial level before bovine embryo 
genome activation (EGA; Crocco et al., 2011). Nonetheless, for these and other 
reasons, such as minimizing the risk of disease transmission and evaluating the effect 
of specific factors during IVC on embryo performance, there is continuing demand for 
reliable and scientifically well defined cell and tissue culture methods (van der Valk et 
al., 2010). However, during the process of defining systems we must consider their 
adaptation to the physiological requirements of the embryo during culture (Thompson, 
2000). Table 3 summarizes consensus results in the literature for blastocyst rates 
among the common livestock animals utilizing varied culture media formulations. 
Optimal defined culture media for embryo production appears to require a 
combination of hormones, cytokines and antioxidants in order to replace serum or 
albumin with other macromolecules. Recently, more competent embryos have been 
reported when growth factors or cytokines are added either singly or in combination to 
the embryo culture media throughout the preimplantation stages. The major roles of 
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these factors are in regulation of apoptosis, cell differentiation and proliferation. Table 
4 summarizes the effects of various growth factors and hormones for improving 
embryo development in defined media. 
An important hormone for potential relevance in vitro is progesterone (P4) 
because of its requisite role in the maintenance of pregnancy. Results from trials 
studying the effects of P4 on preimplantation embryo development have been 
controversial. The hormone itself is lipophilic and in culture systems that usually rely 
on overlay of oil to avoid droplet evaporation, the P4 may be depleted from the media 
by the time embryos are transferred into the droplet. A study by Clemente et al. (2009) 
identified P4 receptors in preimplantation bovine embryos, but found no effect of in 
vitro P4 supplementation on elongated embryos post hatching. Considering earlier 
stages, embryos supplemented with a low dose of P4 (1 ng/ml) metabolized more 
glucose at postcompaction stages (Larson et al., 2011). Although P4 supplementation 
during culture did not improve embryo characteristics, these authors concluded that 
subtle changes in overall glucose partitioning and metabolism could have long term 
effects. In a more recent report, Ferguson et al. (2012) reported that the addition of P4 
to the embryo culture stimulated the rate of embryo development and improved 
hatching rates. More research on effects of P4 in vitro seem warranted since the rise in 
circulating P4 levels that occurs after estrus and insemination is coincident with the 
embryo entering the uterus and the timing and switch from low to higher glycolytic 
rates.  
A promising area for the improvement of single embryo culture systems is the 
utilization of embryonic lipid stores as an alternate source of energy especially for 
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species such as bovine, equine, and porcine where implantation occurs later than in 
human and murine species (Sturmey et al., 2009; Sutton-McDowall et al., 2012). In 
invertebrate species lipid droplets seem to regulate the function of proteins related to 
embryo genome activation (EGA) by maintaining them in an inactive state. Thus, lipid 
stores may function not only as a source of energy reserve, but also as a potential 
reservoir for signaling factors that play a role in cellular fate, in a spatiotemporal way, 
for mammalian early embryo development (Kim et al., 2012). 
Oxidative stress and antioxidants  
Most research on IVP has focused on the damaging effects of an oxidative 
environment and the inherent creation of reactive oxygen and nitrogen species 
(RONS) that may impair embryo development. The reduced glutathione (GSH) to 
oxidized glutathione (GSSG) ratio is the usual indicator of choice for measuring the 
redox status. Based on ratios of GSH/GSSG, the cytoplasm is a strong reducing 
environment whereas the endoplasmic reticulum (ER) is significantly less reducing 
(Rand and Grant, 2006). Consequently, excessive supplementation of reducing agents 
in media to offset oxidative damage has resulted in controversial outcomes as slight 
redox unbalances are detrimental for embryo development. 
In eukaryotic cells there are two major systems responsible for maintaining a 
reduced state inside the cell. Glutathione and Thioredoxin (Trx) systems along with 
their respective reductases provide protection to proteins and enzymes during catalytic 
reactions in an interactive way (Rand and Grant, 2006; Koháryová and Kolárová, 
2008) in order to maintain the reducing environment of the cell, to detoxify RONS 
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(Dunn et al., 2010), and to modulate various cellular activities such as gene 
expression, cell proliferation, survival and cell death (Sun and Regas, 2010). Disulfide 
bonds provide another mechanism of cellular protection and are essential for the 
folding and stability of proteins at the level of the ER. Under normal conditions, the 
most commonly used antioxidants such as β-mercaptoethanol (β-ME), GSH and 
taurine provide a buffer against oxidizing agents. However, an excess of antioxidants 
may compete for oxidizing equivalents in the ER and, thereby, promote an unfolded 
protein response due to an excessive accumulation of misfolded proteins (Rand and 
Grant, 2006). Consequently, an excess of reductants would disrupt not only multiple 
ER functions, but also signaling pathways that rely on low physiological 
concentrations of RONS as well as redox-sensitive transcription factors viz. reducing 
stress (Rand and Grant, 2006). Alternatively, an excess of RONS produced without 
sufficient antioxidant protection may lead to disequilibrium of the redox balance viz. 
oxidative stress characterized by RONS targeting and damaging DNA, RNA, protein 
and lipids (Koháryová and Kolárová, 2008). 
Many attempts to minimize oxidative stress have been made during the past 
two decades. Culturing embryos under hypoxic conditions (i.e. 5-10% O2) in 
combination with antioxidants partially compensated for the antioxidant contributions 
of co-culture cells. Studies using antioxidants under high and low oxygen tension 
conditions have resulted in controversial findings. Choe et al. (2010), using the swine 
model, studied the effect of the combination of GSH, β-ME and cysteine on embryo 
development. Treatment groups had a greater number of developing embryos than the 
control, however, higher concentrations of these antioxidants might have increased 
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embryo yield because high O2 culture conditions (20% O2 and 5% CO2) were used. In 
contrast, Dovolu et al. (2011) working with guaiazulene (a component of various 
chamomile species with antioxidant properties) showed that under low oxygen tension 
(5% O2) there was no positive effect on embryo rates when compared to control.  
Melatonin has been reported to be a potent antioxidant. This hormone is a 
scavenger of free radicals and recent findings on melatonin either alone or in 
combination with taurine have been reported in buffalo and bovine species 
(Manjunatha et al., 2009; Takada et al., 2010). Overall, there were positive effects in 
the treatment groups compared to the controls for both studies, however, they used 
20% O2 and 5% CO2 conditions. Thus, the use of antioxidants may yield greater 
benefits under high O2 tension.  
Recent attention has been given to phytochemicals containing antioxidant 
properties (Liu, 2004). For example, Jang et al. (2009) and Lee et al. (2011) tested the 
effects on bovine embryos of astaxanthin (carotenoids group) and 3, 4-
dihydroxiflavone (phenolics group), respectively. Based on their culture conditions, 
they demonstrated that these phytochemicals had positive effects on cell proliferation, 
differentiation, and viability i.e. reduction of ROS, lipid peroxidation and apoptotic 
cell numbers. 
Due to the increased interest in the redox systems and their interactions, more 
studies that not only measure the effectiveness of single factor supplementation, but 
also consider potential interactions of a cocktail of factors, antioxidant and hormones 
are needed, especially for single embryo culture. Lei et al. (2007) mentioned that 
expression of EGF receptor may participate in the regulation of glutathione 
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peroxidase-1 (GPX-1) along with GSH to maintain cellular homeostasis. Since both 
GPX-1 and Trxr are selenoenzymes, research on the interaction of both enzymes in 
light of the unfolded protein response status is of interest, especially when the GSH 
system belongs to the primary redox buffer that is competing with the Trx system for 
reducing equivalents. In addition, there seems to be an effect of preimplantation factor 
(PIF) on the regulation of Trx and GSH systems. This 15-AA polypeptide is a 
conserved sequence throughout mammalian species and it is produced by the viable 
embryo. Thus, integrating PIF on redox studies could provide more information on the 
regulation of the balance of such important systems. 
The use of alternative macromolecules 
Recent evidence has shown that embryos cultured in vitro remain inferior to 
those developed in vivo (Kuzmany et al., 2011). In addition, when embryos are 
cultured individually this inferior quality is more marked. However, culture of single 
embryos under defined conditions is highly desirable in human clinical situations, but 
presents challenges, e.g. single embryos (or COCs) in culture lack the benefits of 
embryotrophic factors from group culture and serum or albumin in the media. 
Variation from batch to batch of serum or albumin (i.e. contamination) is of concern 
and could potentially impair embryo development. Consequently, in an attempt to 
standardize the IVP production by making more defined culture media, many 
synthetic macromolecules have been used to replace animal-derived products. These 
include polyvinyl alcohol (PVA), polyvinyl pyrrolidone (PVP), ficoll and knockout 
serum replacement (KOSR [defined cocktail of factors]), but the results of using these 
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synthetic macromolecules have generally been disappointing. More promising results 
have been reported for recombinant human serum albumin (rHSA) in combination 
with hyaluronan (HA) that are the most abundant macromolecules in the female 
reproductive tract (Lane et al., 2003; Palasz et al., 2009). Table 5 summarizes different 
macromolecules and/or approaches to culture embryos.  
Alternative new culture approaches 
Under large-scale embryo production for livestock, group size in culture may 
not represent issues since the number of embryos per session typically allows groups 
of 10-25 embryos per droplet (usually 20-100 μL). By contrast, assisted reproduction 
clinics offer individualized services that represent a challenge in terms of group size 
culture conditions. Thus, reliable single (or small-group) COCs/embryo culture 
systems that can be replicated are necessary.  
In a prospective study with human oocytes submitted to either IVF or ICSI, 
Ebner et al. (2010) tested a new type of culture dish and measured the effects of 
individual culture, individual culture with contact to neighbors, and group culture of 
zygotes (9-15). The results showed that group culture was best in terms of compaction 
and blastulation when compared to individual culture. Although there was only a trend 
for more births under group-culture treatment, the authors recommended group culture 
and also suggested a reduced volume of culture droplet or increased embryo density. 
Other studies investigating the effects of small-group or single embryo culture and 
continuous vs. sequential media have been encouraging. In mice, the effect of embryo 
density and microdrop volume on embryo development was tested (Vutyavanich et al., 
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2011) and overall, no differences were found in terms of cleavage or blastocyst 
formation. However, embryos cultured singly had fewer ICM and TE cells than those 
cultured in groups. Nonetheless, groups as small as 2 embryos (in a microdrop from 
0.5-2.0 μL) gave similar results to group culture in a 10 μL droplet. The effect of 
polyester mesh sections on the culture of COCs and embryos has been tested in an 
effort to reduce the labor inherent to the manual preparation for well of the well 
(“WOW”) dishes. Results have indicated that oocyte maturation and embryo 
development may be carried out in polyester meshes (~170 μm opening) with similar 
developmental rates as those obtained by WOW or control group-culture (Somfai et 
al., 2010; Matoba et al., 2010).  
A human IVF study investigated the effects of continuous uninterrupted single 
medium culture without replacement of fresh media vs. sequential media (Reed et al., 
2009). No significant differences were detected between the two approaches in terms 
of embryo quality for d-3 transfers, however, for transfers at d-5 the continuous 
approach resulted in a greater number of suitable embryos than sequential media. In 
agreement, Paternot et al. (2010) demonstrated that although embryo quality was 
similar following uninterrupted culture vs. sequential media, the embryo utilization 
rate (embryos available for vitrification or fresh transfers over the total number of 
embryos) was higher for continuous culture. Interestingly a study using the bovine 
model reported that preimplantation embryonic development was better in a two-step 
sequential culture method than in the uninterrupted single media conditions as relative 
quantitative expression of gene markers related to embryo development showed higher 
values (Saadeldin et al., 2011). Furthermore, Kepkova et al. (2011) in a comparison of 
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two commercial culture media reported higher levels of relative mRNA expression in 
groups cultured in Ménézo B2 media indicating that the embryos were able to develop 
faster compared to those cultured in COOK media.  
The emergence of microfluidic technology combining engineering and biology 
knowledge has led to a promising and innovative option for the in vitro culture of 
gametes and embryos in both static and dynamic ways. One of the obvious benefits of 
this technology would be the reduction of the “human factor” which would imply less 
manipulation of embryos and gametes, minimal fluctuations in the in vitro 
microenvironment and providing a more physiological nutrient delivery in the culture 
media as the embryo develops. Consequently, embryonic stress would be substantially 
reduced and the embryo viability could be enhanced (Feugang et al., 2009). 
Microfluidic approaches attempt to replicate more closely the early events of 
embryogenesis normally occurring during in vivo conditions (Krisher and Wheeler, 
2010). The principle of this technology is basically a very small working volume of 
medium, in the nano-to-micro liter range. Two categories, static and dynamic, are 
recognized: in the dynamic system, the embryo remains stationary in a microwell in 
which media can be slowly changed. Krisher and Wheeler (2010) reviewed several 
prototypes of microfluidic systems, either static or dynamic, reporting overall positive 
results (equal to or better than control groups). However, in some cases it appeared 
there was decreased embryo development and these inconsistencies could not be 
explained. Current challenges to overcome are the material selection and the flow rate 
(Thompson, 2007; Feugang et al., 2009). Microfluidic technology is progressing 
rapidly as it seems that imagination is the only limiting factor when designing 
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microfluidic devices (Krisher and Wheeler, 2010). For example, Kim et al. (2009) 
developed a microfluidic in vitro culture system for mechanical stimulation of bovine 
embryos. Their system emulated the peristaltic constriction that normally occurs in 
vivo in the oviduct by designing microchannels with constricted areas. The results 
were positive and suggested that this constriction contributes to the early development 
of bovine embryos in ART systems.  
Static microfluidic models using WOW systems have been used by several 
research groups and in most cases cleavage and blastocyst rates were not different 
compared to controls cultured in the usual groups. Taka et al. (2005) reported that 
WOW with a diameter of 1000 μm improved blastocyst rate in small groups (4-
5/WOW) of swine embryos after ICSI (without exogenous activation) when compared 
to other groups (24.6 % vs. <13 %, respectively). Hoelker et al. (2010) concluded that 
a microenvironmental embryo density of 1:0.269 μL and a macroenvironmental 
embryo density of 1:30 μL were most successful for culturing bovine embryos in 
WOWs. The use of the WOW system to produce monozygotic twin bovine calves 
(Tagawa et al., 2008) using the blastomere separation technique resulted in higher 
pregnancy rates compared to the monozygotic twin blastocysts obtained by 
conventional bisection of in vivo derived blastocysts (78.9 vs. 40%). This may have a 
significant impact for the livestock industry and for research purposes as progeny 
would be derived from genetically valuable animals that could also be used for 
comparative studies by providing animals with an identical genetic background, 
thereby reducing the need for higher numbers of experimental units to reach statistical 
power.  
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Polydimethysilixane (PDMS) is widely used for manufacture of microfluidic 
devices due to its physical properties and low cost. Akagi et al. (2010) cultured bovine 
embryos using PDMS microwell plates and found no effect in terms of blastocyst 
development or the proportion of ICM and TE cells for embryos compared with those 
cultured in groups of 20 embryos without PDMS microwell plates. Han et al. (2010) 
and Ma et al. (2011) reported novel approaches using microfluidic devices capable of 
manipulating oocytes, which also enhanced embryo development. These positive 
results suggest that microfluidic devices simplify the overall IVP by reducing the 
human factor and also by tracking single embryo development. 
Microfluidic technology allows the addition of a powerful tool such as time 
lapse cinematography (TLC) which could facilitate selection of the top quality 
embryos monitored in real time. TLC has lead to better understanding of fertilization 
and early preimplantation embryonic development that may have an impact later on 
pregnancy rates (Mio and Maeda, 2008; Niimura et al., 2010). Recently, Pribenszki et 
al. (2010) reported pregnancy and birth of a healthy infant in a single human IVF case 
using TLC in combination with WOW to select a single embryo for transfer. Although 
a single case is not sufficient to validate the usefulness of this approach, the authors 
encouraged application of TLC in combination with WOW. In bovine embryos, TLC 
in combination with polystyrene based-microwell culture resulted in pregnancy rates 
higher (51.7%) than control (21.9%) at day 60 post embryo transfer (Sugimura et al., 
2010). This approach allowed the tracking and selection of the healthier bovine 
embryos for transfer. In addition, the risk of pregnancy loss was minimized. The 
authors did suggest that PDMS might absorb medium components such as 
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embryotrophic factors, making the novel polystyrene-WOW embryo culture system 
preferable.  
The development of the “IVP lab-on-a-chip” would have a significant impact 
especially for human IVF since it would allow integrating oocyte positioning, sperm 
selection, fertilization medium replacement, embryo culture and monitoring of embryo 
development. Optimizing sinlge embryo culture conditions will play a pivotal role in 
the development of this new technology. In addition, the current challenge is 
integrating all the phases of the IVP into an “IVP-lab-on-a-chip” in vitro maturation 
and cumulus removal included on this device. Equal or higher quality standards than 
the current conventional methods and reliable results would be expected in order to be 
adopted by clinicians and embryologists. 
Assessing embryo quality 
In addition to the TLC, there are other non-invasive approaches for assessing 
the quality of embryos either for fresh transfer or cryopreservation. For example, assay 
of preimplantation factor (PIF) in media (Stamatkin et al., 2011b) may serve as a 
universal embryo viability marker since it is secreted by viable embryos of several 
species including mice, cattle and humans. This approach may represent a reliable tool 
to facilitate embryo selection for transfer into the recipient patient. Another non-
invasive technique using the nanorespirometer to measure oxygen consumption as a 
marker of embryo viability has been reported (Lopes et al., 2010). Based on the same 
principle, the development of an embryoscope that combines time-lapse 
cinematography and an oxygen microsensor has been used to measure oxygen 
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consumption rates and to determine embryo developmental competence (Lopes et al., 
2010).  
Using amino acid profiling as another non-invasive approach, Sturmey et al. 
(2010) compared the developmental potential of bovine in vivo and in vitro derived 
embryos. They were able to detect differences between the two embryo sources, 
through increased AA media depletion by the in vitro group and also a sex-specific 
preference for amino acid depletion (Table 2). In humans, metabolomic profiling using 
near infrared spectroscopy is another effective non-invasive tool to predict embryo 
development (Seli et al., 2011). Non-invasive means of evaluating embryo quality and 
potential can be used to optimize decisions for embryo transfers (single vs. multiple) 
or cryopreservation procedures (by embryonic developmental stage) for maximum 
success (Guerif et al., 2009; Wang et al., 2010; Seli et al., 2011; Solé et al., 2011).  
Although non-invasive approaches are improving, invasive ones have been 
extremely helpful in finding candidate genes to predict embryonic survival. Rekik et 
al. (2011) showed that it may be possible to establish transcriptomic landmarks 
specific for embryonic stage as critical markers for embryo quality. Bovine 
transcriptome analysis has revealed that part of the decreased reproductive rate in pure 
breed livestock species might be related to a high degree of inbreeding (Lazzari et al., 
2011). Other transcriptomic differences have been reported for IVF blastocysts vs. 
degenerative embryos (Huang et al., 2010), in vivo vs. in vitro derived embryos 
(Kepkova et al., 2011), and blastocysts that did or did not result in pregnancy after 
transfer (Ghanem et al., 2011). In addition, within these analyses, the relative 
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expression of 18 genes was similar for in vivo and in vitro derived bovine embryos 
and whether resulting in delivery or not (Ghanem et al., 2011). 
Interactions between the embryo and its maternal environment to consider for 
IVP 
Initial gamete interaction, zygote development and embryo genome activation 
occur in vivo in the oviduct (Besenfelder et al., 2010). Embryo co-culture systems 
have been used to study maternal cross-talk during early preimplantation stages. 
Besenfelder et al. (2010) described the benefits for in vivo culture of in vitro derived 
bovine embryos using an oviduct culture model. The importance of the tubal-embryo 
interaction is demonstrated by surrogate xeno-oviducts supporting development of 
embryos that are more competent after transfer or more resistant to cryopreservation 
than their in vitro counterparts (Lazzari et al., 2010). Isolated mouse oviducts have 
been used for culturing bovine embryos. Although results were similar to in vitro 
culture, the oviduct demonstrated a remarkable immunotolerance for preimplantation 
embryos across species (Rizos et al., 2010). Co-culture of embryos with oviduct 
epithelial cells is a simpler model to study interactions of gametes and embryos than 
with the oviduct in vitro. Ulbrich et al. (2010) provided an extensive review on the 
bovine epithelial cell process for embryo co-culture systems. However, results should 
be interpreted with caution as the isolation of embryos and cells in this co-culture 
approach does not account for the more complex in vivo system.  
A healthy endometrium is critical for pregnancy to occur especially in 
individuals undergoing repetitive ART. Fertility has been reported to be higher for 
cows with an endometrial thickness >10 mm after ovulation (Wiltbank et al., 2011). 
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Thus, an adequate thickness of the endometrium is recommended before embryo 
transfer. Neuromuscular electrical stimulation has been used in women to improve 
endometrial thickness and such treatment has resulted in a tendency for increased 
pregnancy rates compared to untreated controls (Bodombossou-Djobo et al., 2011). A 
thicker endometrium is associated with increased blood flow which may contain 
embryotrophic factors and substrates for a successful pregnancy and it is an important 
site for immunotolerance processes at the maternal-fetal interface. In a bovine study, a 
nonclassical MHC-I gene was reported to be responsive to cytokines that positively 
regulate pregnancy and suggests that these cytokines are not only involved in the 
preimplantation embryo survival per se, but also function as regulators at this interface 
(O’Gorman et al., 2010; Al Naib et al., 2011). Hill and Gilbert (2008) reported 
reduced overall cell number (particularly reduced trophectoderm cell number) in 
bovine embryos exposed to endometrial fluid recovered from a cow with uterine 
inflammation. The embryo-maternal environment interaction during pregnancy is 
complex and dynamic and future experiments toward single embryo culture in more 
defined conditions may benefit from studies integrating new knowledge from such 
interactions.  
CONCLUSIONS AND FURTHER REMARKS 
In the field of assisted reproductive technologies, in vitro derived embryos are 
still less developmentally competent than their in vivo counterparts. Several steps 
from in vitro maturation to fertilization and culture are not yet fully optimized in vitro. 
There is an increased awareness of the spatio-temporal requirements at several stages 
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of preimplantation embryo development and the different requirements for achieving 
optimal rates of development and quality. Although much can be learned from embryo 
co-culture systems that provide important insights, completely defined and optimized 
media is the goal. To obtain serum-free media for culturing embryos (especially single 
embryo culture) with minimum risk of disease transmission, there is a need to know 
the most critical nutrients, metabolic regulators, cytokines and hormones for each 
stage of embryo development. Animal models such as bovine IVP could be better 
exploited and results extrapolated to other species including the human. Important 
tools such as the non-invasive evaluation approaches for selection of elite quality 
embryos either for transfer or cryopreservation might be routinely used for minimizing 
the number of embryos transferred, assuring embryonic competence, and resulting in 
the birth of healthy offspring. Nevertheless, the use of invasive approaches such as 
transcriptome evaluation will continue to be a reliable tool to discover more 
relationships between embryonic markers and the maternal environment. 
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TABLES 
Table 1. Important milestones in embryo culture media. 
Event  Reference 
-First IVF reported using the golden hamster 
model. 
 
Yanagimachi and Chang (1964). 
-Tervit et al. developed a synthetic oviduct 
media based on the biochemistry and 
physiology of the ovine oviduct. 
 
Tervit et al. (1973). 
-Bavister and co-workers did intensive work 
during the 70’s to meet in vitro embryo 
nutrient requirements. 
 
Bavister et al. (1983). 
-Biggers and co-workers created KSOM and 
2-cell block in mice was overcome 
Summers et al. (1995). 
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Table 2. Past and current focus on embryo metabolism in livestock species. 
Metabolic area Factor studied* Reference 
-Modulation of glucose 
consumption at precompaction 
stage 
EDTA Reviewed in Thompson et al. (2000).  
-Enhancement of glucose 
consumption at pericompaction 
stages 
DNP Thompson et al. (2000). 
PES De La Torre-Sanchez et al. 
(2006). 
HIF Harvey (2007). 
-Utilization of internal lipid 
stores 
 Sturmey et al. (2009). 
L-Carnitine Sutton-McDowall et al. 
(2012). 
-Progesterone-related nutrient 
metabolism 
AA +Glucose Clemente et al. (2009). 
 Hugentobler et al. (2010). 
 Garcia-Herreros et al. 
(2012). 
-Sex-dependent nutrient 
requirements 
AA Sturmey et al. (2010). 
Glucose Garcia-Herreros et al. 
(2012. 
*Abbreviations: EDTA (ethylenediaminetetraacetic acid), DNP (2, 4—Dinitro 
Phenol), PES (Phenazine ethosulfate), HIF (Hypoxia inducible factors) and AA 
(Amino acids).  
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Table 3. Consensus average embryo blastocyst rates among large animal domestic 
species cultured with different media formulations.  
Media 
type 
Species In vitro 
procedure 
Blastocyst rate 
(%) 
Reference 
KSOM Porcine IVF 32.1 Hashem et al. (2006) Bovine  IVF  37.1 Felmer et al. (2011) 
SOFaa 
Porcine Cloning 38.0a Lagutina et al. (2006) 
Ovine  IVF  24.1 Garcia-Garcia et al. 
(2007) 
Ovine  IVF  28.7 Wan et al. (2009) 
Bovine IVF 34.9 Sanches et al. (2013) 
CR1aa 
Equine ICSI 25.5b Matsukawa et al. (2007) 
Ovine  IVF  25.5 Wan et al. (2009) 
Bovine IVF 36.1 Somfai et al. (2010) 
DMEM/F-
12 
Equine ICSI 42.0c Hinrichs. (2012) 
NCSU-23 
Porcine IVF 30.5 Hashem et al. (2006) 
Porcine Cloning 28.5a Lagutina et al. (2006) 
Porcine IVF 32.8 Kim et al. (2012) 
PZM Porcine IVF 27.4
d Hu et al. (2012) 
Porcine IVF 27.5e Yoshioka et al. (2012) 
IVD101 Bovine IVF 37.1 Hoshi (2003) Bovine IVF 21.7 Somfai et al. (2010) 
Gardner 
(G1/G2) 
Ovine IVF 21.5 Garcia-Garcia et al. 
(2007) 
Bovine IVF 27.8 Sanches et al. (2013) 
IVF VET 
Solutions Bovine IVF 69.0
f Albuz et al. (2010) 
aOverall average blastocyst rate from 3 different donor cell lines. 
bBlastocyst rates originated from expanded oocytes. 
cHighest blastocyst rate reported for equine ICSI-produced embryos. 
dBlastocyst rate achieved by supplementing Vitamin C (20μg/ml). 
eBlastocyst rate reported at day 5 post IVF. 
fHigh blastocyst rate achieved by a novel approach, stimulated physiological oocyte 
maturation (SPOM), during IVM. 
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Table 4. Supplementation with embryotrophic factors towards improving (more) defined media. 
Factor Actions Reference 
Colony-stimulating factor 2 (CSF2) Blocked apoptosis in bovine embryos through regulatory actions on apoptosis genes. 
CSF2-embryos tended to secrete more IFNτ. 
Loureiro et al., 2011a and b 
Epidermal growth factor (EGF) Besides its role on proliferation, migration and differentiation, EGF is involved in 
reduction of apoptosis during preimplantation and placentation. Higher cryotolerance has 
been reported in bovine embryos treated with EGF at IVM. 
Gordon, 2003; Hambruch et 
al., 2010; Dhali et al., 2011 
Fibroblast growth factor 2 (FGF2) FGF2, but more importantly FGF2 receptor activity were necessary for optimal 
development 
Fields et al., 2011 
Preimplantation factor (PIF) Involved in modulation of local immunity, promoting decidual proadhesion molecules 
and enhancement of trophoblast invasion. In addition, PIF was found to be expressed in 
the trophoblast layer during the first two trimesters of human pregnancy. 
Stamatkin et al., 2011a and b; 
Weiss et al., 2012; Barnea and 
Sharma. 2006 
Insulin, transferrin and sodium selenite 
(ITS) 
Insulin exerted its actions on glucose transport and AA uptake along with antioxidant 
protection from transferrin and selenium. 
Gordon, 2003 
GH (somatotropin) and IGF-I In combination stimulated embryonic development. Although the GH effects have been 
reported as not mediated by IGF-I in the bovine IVM model, both hormones appear to 
have critical roles in the modulation of apoptosis and metabolism. Embryonic 
development is stimulated by the combination. 
Moreira et al. 2002; Bevers 
and Izadyar, 2002; Kölle et al., 
2002; Köle et al., 2004; 
Pozzobon et al., 2005; 
Kuzmina et al., 2007; 
Velazquez et al., 2008; 
Velazquez et al., 2011 
Makarevich et al., 2012 
IGF-I, IGF-II, FGF2, transforming 
growth factor beta1 (TGFβ1), leukemia 
inhibitory factor (LIF) and CSF2, 
singly and in combination. 
Results from the combination were similar to culture under serum conditions, but not 
greater. 
Neira et al. 2011 
Activin A In bovine species, fourth cell cycle (lag phase) is longer for in vitro derived embryos 
than in vivo counterparts (~50 hr vs. ~24 hr). Use of activin A shortened the lag phase 
and was also beneficial at later (5-8 days post insemination [dpi]) stages, however, more 
rapid rates of development were associated with higher rates of apoptosis. 
Gordon, 2003; 
Trigal et al. 2011 
Thyroid hormone (TH) Important during early pregnancy but the use in vitro is minimal. On the bovine embryo 
TH is involved in lowering apoptotic rates as well as improved hatching rates post 
thawing for cryopreserved embryos. 
Ashkar et al., 2010 
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Table 5. The use and benefits of alternative macromolecules in bovine embryo culture systems. 
Macromolecule Culture Main findings Reference 
rHSA + HA Group Inclusion of both macromolecules plus citrate 
resulted in high rates of bovine blastocyst 
development. 
Lane et al., 2003. 
BSA + HA Group The addition of BSA was necessary throughout 
the entire culture period and resulted in higher 
blastocyst rates irrespective of HA treatment. 
However, supplementation of HA at day 4 post 
insemination increased mitochondrial DNA 
(mtDNA) copy numbers at the blastocyst stage. 
Palasz et al., 2009. 
KOSR Group KOSR at 20% O2 yielded the highest pre-
implantation embryo rates. 
Mingoti et al., 2011. 
human embryonic stem cell 
derived bioactive material 
(hES-BM) 
Group Results from staining methods and measures of 
gene expression of pluripotency, embryogenesis 
and growth markers were significantly higher 
than in the control group treated with fetal bovine 
serum. The authors concluded that hES-BM 
could be used as a new supplement for bovine 
preimplantation embryo development. 
Kim et al., 2011. 
Agarose-embedded helper 
embryos 
Group (co-
culture) 
Enhanced developmental competence and 
embryo quality markers e.g. involved in 
implantation and normal calf delivery (PGHS2, 
TXN, PLAU). 
Senatore et al., 2010; Deb et 
al., 2011. 
Somatic cell feeders Group Cryotolerance was positively influenced by the 
presence of somatic cells and was reflected in 
survival and hatching rates as well as differential 
cell counts. 
Shirazi et al., 2009. 
Heterologous cumulus cells Single (co-
culture) 
Gene expression for qualitative markers (TP53, 
BAX, SHC1, SHC and IGF2R) was reportedly 
similar for groups of embryos co-cultured singly 
or in groups with or without heterologous 
cumulus cells. 
Goovaerts et al., 2011. 
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Figure 1. Summary of embryo metabolic events during preimplantation. 
 
 
a) Within the cumulus oocyte complex, the oocyte emphasizes glycolysis and pentose phosphate (PPP) pathways. Glycolysis 
provides an important source of energy via hexokinase activity. PPP provides reducing equivalents (NADPH) and production of 
pentoses for the synthesis of purines. The hexosamine biosynthesis pathway (HBP) is important for extracellular matrix expansion 
of the cumulus cells and o-linked glycosylation of important amino acids residues involved in the cell cycle progression. Polyol 
pathway provides sorbitol and fructose as other sources of energy and it contributes to maintenance of redox balance. b) After 
fertilization, the zygote depends on tricarboxylic acids such as pyruvate and lactate as the primary energy sources. c) Bovine 
morula compaction is an important event that occurs at day five after fertilization in the bovine embryo and marks the beginning for 
higher glucose consumption. Thus, in preparation for a hypoxic environment in the uterus and coincident with the increase in 
plasma progesterone (P4), the preimplantation embryo at morula stage switches its metabolism from low to high glucose utilization 
via glycolysis and PPP pathways. 
 
 65 
CHAPTER THREE: EFFECT OF CONJUGATED LINOLEIC ACID 
SUPPLEMENTATION ON IN VITRO BOVINE EMBRYO PRODUCTION 
AND CRYOPRESERVATION 
 
 
V. A. Absalón-Medina†, S. J. Bedford-Guaus‡, R. O. Gilbert‡, L. C. Siqueira1, G. 
Esposito2, A. Schneider3, S. H. Cheong‡, and W. R. Butler†* 
 
 
Submitted, Journal of Dairy Science 
 
 
†College of Agriculture and Life Sciences, Animal Science Department. Cornell 
University, Ithaca, NY 14853. USA. 
‡College of Veterinary Medicine, Department of Clinical Sciences. Cornell University, 
Ithaca, NY 14853. USA 
1Universidade Federal de Santa Maria, Santa Maria, RS 8690. Brazil.  
Email: lsvet@bol.com.br  
2Università degli Studi di Napoli Federico II, Portici, Napoli 80138. Italy. 
 Email: Giulia.Esposito@up.ac.za  
3Universidade Federal de Pelotas, Pelotas, RS 96001. Brazil. 
 Email: augustoschneider@gmail.com  
*Correspondence e-mail: wrb2@cornell.edu 
 66 
ABSTRACT 
Conjugated linoleic acid (CLA) isomers of linoleic acid (18:2 n-6) and other 
polyunsaturated fatty acids can affect the lipid profile and signaling of cells and 
thereby alter their function. A total of 6,267 bovine oocytes were used in this project 
in a structured series of experiments to determine the optimal isomer dose and stage of 
development for supplementation with CLA, cis 9, trans 11 and trans 10, cis 12, to 
improve in vitro embryo production. In experiment 1, high doses of CLA during in 
vitro maturation (IVM) were compared with high or low doses during the entire in 
vitro embryo culture of parthenogenetic embryos. High and low doses of CLA ranged 
from 50 to 200 μM and from 15 to 50 μM, respectively. In experiment 2 low doses of 
CLA were tested during the entire culture after in vitro fertilization. Experiment 3 
studied the effect of low doses of CLA at specific points during in vitro fertilization 
and embryo culture. In experiment 4, resistance to cryopreservation viz. vitrification of 
embryos supplemented with CLA was assessed by post-thaw survival rates. In 
experiment 1 there were no effects (p > 0.05) of CLA on maturation or cleavage rates 
(92.2 ± 1.6 % and 78.3 ± 4.1 %, respectively). When CLA was provided at maturation 
only, blastocyst rates remained similar across treatments averaging 28.9 ± 5.1 %. 
However, high doses of CLA during the entire embryo culture period decreased (p < 
0.05) blastocyst rates (7-15%) in a dose dependent manner. Although no differences in 
blastocyst rates were observed using low doses of CLA during the entire culture, these 
rates were lower (18.4 ± 1.9 %) compared to groups treated with CLA at maturation 
only. Progesterone concentrations in maturation media were significantly higher for 
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the three high dose treatment groups combined i.e. 50 μM, 100 μM and 200 μM as 
compared to control (0.77 ± 0.09 ng/ml vs. 0.55 ± 0.09 ng/ml; p < 0.05). Low doses of 
CLAs (15 μM to 50 μM) in IVM media did not affect progesterone concentrations. In 
experiment 2, no differences were observed among treatment groups in cleavage rates 
(average 84.9 ± 1.9 %) and blastocyst rates in response to CLA were generally similar 
to control (38.2 ± 2.3 %). In experiment 3, low doses of either CLA isomer during the 
entire IVC did not affect cleavage rates (89.6 ± 1.6 %), however, blastocyst rates were 
significantly reduced for t10,c12 CLA and c9, t11 when compared to control (24.6 ± 
1.8 % and 30.8 ± 1.4 % vs. 34.18 ± 1.2 %, respectively) and the negative effect (p < 
0.05) was enhanced by time in culture, especially in the presence of t10, c12 CLA. In 
experiment 4, vitrifying embryos supplemented with a high dose of CLA c9, t11 
during the final 36 hr of IVC resulted in the highest survival rates and the quality of 
thawed embryos was comparable to control embryos not undergoing vitrification. In 
conclusion, CLA supplementation did not improve embryo production, but inclusion 
of CLA c9, t11 in vitrification protocols improved post-thaw survival of bovine 
embryos produced in vitro.  
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INTRODUCTION 
Conjugated linoleic acid (CLA) comprises a group of polyunsaturated fatty 
acids (PUFA) derived from linoleic acid (C18:2n-6) during biohydrogenation by 
ruminal flora in cattle and sheep. CLA is also produced from delta-9 desaturation of 
vaccenic acid (trans 11 18:1; Bougnoux et al., 2009). Between the two CLA isomers, 
cis9, trans11 (c9, t11) is substantially more abundant than trans10, cis12 (t10, c12; 
Lock and Bauman, 2004; Bauman et al., 2008). These CLA isomers and other PUFAs 
can affect the membrane lipid profile and signaling of cells thereby altering their 
function in vivo or in vitro (Pereira et al., 2008; Fouladi-Nashta et al., 2009; Marei et 
al., 2009; Al Darwich et al., 2010). Regarding changes in lipid composition, CLAs 
become relevant for the improvement of some assisted reproduction technologies such 
as cryopreservation of gametes and embryos (Pereira et al., 2007; Pereira et al., 2008; 
Pereira and Marques, 2008). Embryos may suffer considerable morphological and 
functional damage and the extent of the injury as well as differences in post thaw 
performance may be highly variable depending on the developmental stage and origin 
(i.e. in vitro produced or in vivo derived embryos). Currently, there are two methods 
of choice for oocyte and embryo cryopreservation: slow freezing or vitrification, of 
which the latter seems to yield better results when working with relatively low 
numbers of embryos (Pereira and Marques, 2008). Cytoplasmic lipid content and lipid 
composition of membranes are of concern for in vitro embryo production since they 
can be affected by culture media in ways that increase their vulnerability to damage 
during cryopreservation procedures.  
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In regard to media composition, supplementation with serum may yield higher 
blastocyst rates and improve overall embryonic performance; however, serum 
supplementation also increases cytoplasm lipid uptake and lowers phosphatidyl 
choline and cholesterol esters (Pereira et al., 2007; Al Darwich et al., 2010). 
Conversely, when serum-containing embryo culture medium was supplemented with 
CLA t10, c12, lipid droplet formation was reduced (Pereira et al., 2008). The authors 
proposed that embryo incorporation of CLA t10, c12 during culture increased 
membrane fluidity thus conferring embryos with a greater resistance to 
cryopreservation-induced damage. Moreover, it was suggested that CLA t10, c12 
inhibited stearoyl-CoA desaturase (SCD1; delta-9 desaturase) to make embryos less 
vulnerable to chilling stress (Al Darwich et al., 2010).  
In addition to their purported effect in cell membrane function, some fatty 
acids may play roles in cholesterol metabolism and thus contribute in the regulation of 
steroidogenesis (Fouladi-Nashta et al., 2009). Along these lines, there is a current 
debate as to the effect of progesterone secretion by cumulus cells during oocyte 
maturation. While some studies report that progesterone produced during this time 
period negatively affects later embryo development, others suggest that this hormone 
is involved in the acquisition of oocyte competence and regulation of cumulus-cell 
apoptosis (reviewed by Fair and Lonergan, 2012). The different results among these 
studies may stem from different culture systems or different PUFAs.  
Given the conflicting results among studies, the effect of CLA supplementation 
during in vitro culture of bovine oocytes and embryos requires systematic 
investigation. In the current study, we evaluated the effects of supplementing culture 
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medium with varying concentrations of two CLA isomers for their effects upon bovine 
oocytes, parthenotes and preimplantation embryos. In addition, the effects of CLA 
supplementation upon post-thaw survival of vitrified embryos were also assessed. 
MATERIALS AND METHODS 
Chemicals and Reagents 
All chemicals and reagents were obtained from Sigma-Aldrich Co. (Saint Louis, MO, 
USA), unless otherwise stated.  
Experimental design 
Experiment 1: Effects of CLA supplementation before and after parthenogenetic 
activation of bovine oocytes on embryonic development. 
The aims of this experiment were to compare the effect of high-dose CLA 
supplementation in maturation medium only with high or low-dose CLA 
supplementation throughout the entire culture period. Varying dose ranges were based 
on Pereira et al. (2008) and they were tested for each CLA isomer (c9, t11 and t10, 
c12) where 50, 100, and 200 μM doses were considered ‘High’ and 15, 25, and 50 μM 
doses were considered ‘Low’. For all CLA concentrations, osmolarity was similar 
among CLA groups with carrier bovine serum albumin added to each control group 
and no mineral oil overlay was used. This experiment was divided in three parts 
starting with the evaluation of CLA supplementation during IVM (N= 1062 oocytes), 
high dose CLA supplementation throughout oocyte and embryo culture (N=1756 
oocytes), and low dose CLA-supplementation also throughout (N=1206 oocytes), 
 71 
respectively. Each experiment was performed at least in triplicate. Following oocyte 
removal, in vitro maturation (IVM) media from each treatment group was stored at -20 
°C for progesterone analysis. 
Experiment 2: Effect of low-dose CLA supplementation throughout the entire culture 
period before and after in vitro fertilization (IVF). 
In four replicates a total of 839 oocytes were matured, fertilized and the 
corresponding embryos cultured in vitro. Oocytes were placed in media supplemented 
with CLA or carrier control for the entire in vitro culture period including IVM. 
Treatment groups were a 15 and 25 μM doses for each CLA isomer (c9, t11 or t10, 
c12) and the corresponding carrier controls. Variables measured included cleavage and 
blastocyst formation rates, as well as the neutral lipid (hereafter lipid) content of 
embryos at d-8 post fertilization as assessed by Nile red fluorescent staining under an 
epifluorescent microscope (Bonilla and Hansen, 2009). For all the experiments 
involving staining, fixed embryos were mounted on gold seal fluorescent antibody 
microslides with two etched 10 mm diameter circles surrounded by white ceramic ink 
(Thermo Scientific, USA). Expression of the embryonic survival markers survivin and 
HSP 70.1 genes was measured on d-8 after IVF based on Rief et al. (2002) and Rizos 
et al. (2004).  
Experiment 3: Effect of low-dose CLA supplementation during oocyte maturation 
only, or during IVF and embryo culture process. 
For this trial, the effects of a low (15 μM) dose of the tested CLA isomers were 
evaluated either during IVM only, or during and after IVF. Nine hundred and two 
oocytes were used in four replicates to determine the embryonic viability at d-8 post 
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fertilization. Variables measured were cleavage and blastocyst rates as well as the 
expression of survivin and HSP 70.1 genes. Total blastomere count was assessed using 
Hoechst 33342 staining (Bonilla and Hansen, 2009).  
Experiment 4: Effect of CLA supplementation on embryo viability following 
vitrification and thawing. 
For this experiment 502 oocytes were used across 6 groups including control, 
CLA c9, t11 (15 μM) , CLA t10, c12 (15 μM), CLA c9, t11 (100 μM) and CLA t10, 
c12 (100 μM). The final group was a quality control without CLA supplementation 
and not undergoing vitrification procedures (Control+). Further, groups received 15 
μM CLAs dose only during IVM and remained CLA-free throughout subsequent 
culture. The CLA treatment for the 2 groups with 100 μM of each isomer consisted of 
adding the CLAs for 36 hrs prior to vitrification at d-6.5 post-fertilization. Embryos 
(mostly morula stage) were vitrified (BoviPRO Vit KitTM from Minitube) and 
subsequently thawed according to the manufacturers’ instructions. Immediately after 
vitrification of all embryos were thawed, incubated for 48 hr, fixed, and stained with 
Hoechst 33342. Variables measured included cleavage, blastocyst and post thawing 
blastocyst-survival rates, as well as total blastomere cell counts during survival 
assessment.  
Oocyte recovery and selection 
Bovine ovaries were collected at a nearby abattoir (120 km) and transported to 
the laboratory in prewarmed (30-35 °C) lactated Ringer’s solution at. Cumulus-oocyte 
complexes (COCs) from 2-8 mm follicles were aspirated with an 18G hypodermic 
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needle attached to an aspiration pump unit adjusted to a pressure of 22.5 ± 2.5 ml of 
H2O per minute. Follicular fluid supernatant was removed and the pellet containing 
COCs was transferred to a 15 ml tube where it was resuspended with holding medium 
and contents were poured gently into a 100 mm Petri dish. Holding medium consisted 
of TCM-199 Hank’s salts (Invitrogen, Grand Island, NY) supplemented with 10% 
Fetal Calf Serum (FCS; Invitrogen), 25 μg/ml of gentamicin, 5 μg/ml heparin, at pH 
7.35 ± 0.02 and mOsm = 300 ± 1. After morphological assessment of COCs, only 
those with several layers of granulosa cumulus cells and oocytes with a homogenous 
cytoplasm were selected for use. The entire process was performed within 5 hours 
including transportation. 
In vitro maturation 
Selected COCs were matured in groups of 40 ± 5 for 23 ± 1 hours in 400 μL of 
TCM-199 (Earle’s Salts) enriched with 10% FCS, 22 μg/ml sodium pyruvate, 1 mM 
alanyl-glutamine, 0.1 mM taurine, 0.1 mM cysteamine, 1 μg/ml estradiol, 5 μg/ml 
luteinizing hormone (LH; SIOUX Biochemical, Inc., Sioux Center, IA), 0.5 μg/ml 
follicle stimulating hormone (FSH; SIOUX), 10 ng/ml epidermal growth factor (EGF; 
BD Biosciences—Discovery Labware, MA), 20 μg/ml gentamicin, at pH 7.35 ± 0.02 
and mOsm 300 ± 2, and covered with light mineral oil in a humidified atmosphere at 
38.5° C with 5% CO2 in air.  
Parthenogenetic oocyte activation and embryo culture after maturation 
Parthenotes were obtained following the protocol used by Bastos et al. (2008). 
Briefly, groups of COCs were placed into a small petri dish containing 0.2 mg of 
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hyaluronidase per ml of holding media (pH 7.35 ± 0.02, mOsm 300 ± 2) for 3 min and 
then transferred into a 1.8 ml centrifuge tube. Contents were vortexed at maximum 
speed for 5 min to remove the cumulus cells. Cumulus-free oocytes were then 
resuspended in holding medium and, by fine glass pipette rotation, only those 
presenting a visible polar body indicating successful progression of nuclear maturation 
to the metaphase II stage (MII) were selected and used for parthenogenetic activation 
(PA). Then, MII oocytes were exposed to 5 μM ionomycin for 5 min in M-199 
(Hank’s Salts; Invitrogen, Grand Island, NY) medium supplemented with 0.4% (w/v) 
BSA, rinsed three times in the same medium without ionomycin, and then incubated 
for 5 hr in modified synthetic oviduct fluid medium (SOF, pH 7.4 ± 0.01, mOsm 275 
± 5; Holm et al., 1999) containing 2.8 mM 6-dimethylaminopurine (6-DMAP; Susko-
Parrish et al.,1994). After this short incubation treatment, oocytes were rinsed twice 
and cultured in SOF medium supplemented with 0.4% (w/v) BSA and both essential 
and nonessential amino acids at 38.5° C in 5% CO2, 5% O2 and 90% N2. Rates of 
cleavage were evaluated at 48 hr after activation. After cleavage assessment, PA 
embryos were cultured in groups of ten in 100 μl SOF droplets and transferred every 
two days to fresh medium. Blastocyst rates were assessed at d-8 after activation.  
In vitro fertilization 
Presumptive matured oocytes were transferred to a modified IVF medium 
(Fert-TALP; Parrish et al., 1988) supplemented with 0.5 mM fructose, 6 mg/ml BSA 
FFA Fraction V, 30 μM penicillamine, 15 μM hypotaurine, 1.5 μM epinephrine 
(PHE), 22 μg/ml heparin, 20 μg/ml gentamicin, pH of 7.38 ± 0.01, mOsm 290 ± 2 and 
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covered with light mineral oil in a humidified atmosphere at 38.5° C with 5% CO2 in 
air for 18-22 hours. Frozen semen straws (Genex, Ithaca NY, USA) from a single bull 
and the same ejaculate were used for the 3 IVF experiments, following thawing at 37° 
C for 30 seconds for each trial. Motile sperm were separated from non-motile ones, 
cryoprotectant and debris by Percoll double density gradient (90, 45%) centrifugation 
at 700 x g for 20 min. Subsequently, sperm were washed twice in 5 ml of TL-Semen 
(pH 7.39 ± 0.01, mOsm 295 ± 2) modified Tyrode’s from Parrish et al. (1989) at 300 x 
g for 5 min to remove Percoll. Finally, sperm were adjusted to a final concentration of 
1.5 x 106 sperm/ml using Fert-TALP media; in all cases progressive motility averaged 
at least 50%. 
In vitro embryo culture 
A modified SOF medium (Holm et al., 1999) was used for in vitro embryo 
culture (20 μg/ml gentamicin, pH 7.4 ± 0.01, mOsm 275 ± 5). After fertilization, 
putative zygotes were denuded at maximum vortex speed for 120 sec and transferred 
to a modified SOF (SOFearly) supplemented with 10 μM EDTA, 0.5 mM fructose, 0.4 
% (w/v) BSA FFA Fraction V, 0.1 mM taurine, and then placed in light mineral oil-
covered droplets in a humidified atmosphere at 38.5° C with 5% CO2, 5% O2, and 
90% N2. Following ~48 hr in culture, cleavage rates were assessed and embryos were 
transferred to new droplets containing SOFmid, with essential and non essential amino 
acids, 0.4 % (w/v) BSA FFA Fraction V, and 0.5 mM glucose in a humidified 
atmosphere at 38.5° C with 5% CO2, 5% O2, and 90% N2. After ~96 hr embryos were 
again transferred to fresh SOFmid droplets under the same conditions. Finally, d-7 
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embryos were transferred for the last ~ 24 hr of culture to SOFlate, which was SOF 
supplemented with 5% (v/v) FCS, 0.1 mM taurine and 0.5 mM glucose in a 
humidified atmosphere at 38.5° C with 5% CO2, and 5% O2, and 90% N2. Blastocyst 
rates were calculated as percentages of the original oocyte number. 
BSA:CLA-Complex  
Isomers of CLA, cis9, trans11 and trans10, cis12 (> 90% pure), were 
purchased from Nu-Chek Prep, Inc. (Elysian, MN, USA). The CLA isomers were 
conjugated to fatty acid-free BSA in a 4:1 ratio to prepare 4.5 mM CLA-BSA stocks 
using a method adapted from Keating et al. (2006). Subsequent dilutions were made in 
culture media. 
RNA isolation and transcript quantification 
For total RNA extraction, 100 µL of Qiazol (Qiagen Valencia, CA, USA) was 
added to a known number (13 ± 4) of embryos 8-d after fertilization, vortexed and 
stored at -80oC. Total RNA was isolated and purified using the RNeasy Mini columns 
(Qiagen Valencia, CA, USA) and on-column RNase-free DNase treatment (Qiagen 
Valencia, CA, USA) following the manufacturer's instructions. Then, RNA was eluted 
in a final volume of 15 µL. The reverse transcription reactions were performed using a 
High Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (Applied 
Biosystems Foster City, CA, USA) in a final volume of 20 μL. Real-time quantitative 
PCR was performed using SYBR Green dye to evaluate RPS9 (reference gene), 
survivin, and Hsp 70.1 gene expression with primers listed in Table 1. The amount of 
cDNA in each reaction was standardized to 1 embryo per reaction. The PCR reactions 
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were performed in duplicate in a 25-μL final volume using Power SYBR Green 
Mastermix (Applied Biosystems, Foster City, CA, USA). The PCR reactions and 
fluorescence detection were performed in the ABI Prism 7300 Sequence Detector 
(Applied Biosystems Foster City, CA, USA). For each assay, 40 PCR cycles were run 
and a dissociation curve was included to verify the amplification of a single PCR 
product. Analyses of amplification plots were performed with the Sequence Detection 
Software (Applied Biosystems, Foster City, CA, USA) to determine the counts for 
each sample. Each assay plate contained negative controls and a standard curve with 5 
diluted liver samples (serial dilutions with known RNA concentrations) to determine 
amplification efficiency of the respective primer pair. The relative gene expression 
was calculated using the 2-ΔΔCT method (Livak and Schmittgen, 2001), RSP9 as a 
reference gene, and the control group to correct the fold changes. The average 
coefficient of variation was 1.20%. 
Image acquisition of stained embryos 
All slides were examined using an epifluorescent microscope (Imager Z1; Carl 
Zeiss, Inc.) under a 20× 0.5 NA ECPlan Neofluar (Carl Zeiss, Inc.). Embryo samples 
were excited at 340 nm and 488 nm with emission of 470 nm and 515 nm, to visualize 
DAPI nuclear stain and Nile red, respectively. Images were captured with a cooled 
charged-coupled device camera (AxioCam MRm; Carl Zeiss, Inc.) and processed 
using AxioVision software (version 4.7.2; Carl Zeiss, Inc.). Mean pixel intensity is 
reported as arbitrary units. 
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Progesterone radioimmunoassay 
Progesterone concentrations in IVM media samples were quantified by 
radioimmunoassay (Elrod and Butler, 1993) with the addition of control media to 
standards. Inter and intra-assay coefficients of variation were 5.35% and 5.54%, 
respectively.  
Statistical analysis 
One-way analysis of variance (ANOVA) between treatments was performed 
using JMP version 10 (Statistical Discovery from SAS). If replicates were different 
overtime, we included replicate in our models as a random variable to control for the 
differences between and within experiments. If the main effect was significant all 
means were compared using Tukey HSD. A probability of P <0.05 was considered 
statistically significant and P ≤ 0.1 was considered a trend. Proportional data not being 
normally distributed was arc-sine transformed and results are presented in the tables as 
back transformed data. Likewise, numerical data not being normally distributed was 
transformed to its natural logarithm.  
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RESULTS 
Experiment 1: Effect of CLA supplementation in vitro before and after 
parthenogenetic activation for embryonic development. 
The effect of high dose CLA supplementation in maturation media only 
Supplementation with CLA during IVM did not significantly (P > 0.05) affect 
the rate of oocyte maturation or the proportion of cleaved embryos and blastocysts at 
any dose level of either isomer (Table 2). Progesterone analyses of IVM media 
showed increased levels of progesterone in response to high doses of CLA and this 
effect was directly proportional to the CLA concentration (main effect P < 0.05; 
Figure 1). Conversely, low dose CLA treatment yielded increased progesterone levels 
only for the 50 μM concentration of t10, c12 (Figure 2).  
Effect of high dose CLA supplementation throughout culture 
Results of high dose CLA supplementation (50, 100 and 200 μM for each 
isomer) throughout culture are summarized in Table 3. At 200 µM, CLA t10, c12 
reduced maturation rates as compared to the control group (P < 0.05). Conversely, 
supplementation with 50 µM CLA t10, c12 improved cleavage rates relative to control 
in the group (P < 0.05). Blastocyst rates were depressed by both CLA isomers in a 
dose dependent manner (P < 0.05).  
The effect of low dose CLA supplementation throughout culture 
The effects of low doses of CLA supplementation (15, 25 and 50 μM) for the 
entire culture period are presented in Table 4. No significant differences were 
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observed between groups for maturation rates. The group supplemented with CLA t10, 
c12 at 15 μM showed the highest cleavage rate (86.57%) which was higher (P < 0.05) 
than that for the control group. Conversely no statistical differences were detected 
among groups for blastocyst rates, although 50 μM CLA t10, c12 tended to depress 
blastocyst rate relative to the control group (P = 0.08). 
Experiment 2: Effect of low-dose CLA supplementation throughout culture before and 
after in vitro fertilization. 
Herein we tested the lowest concentrations of both CLA isomers from 
experiment 1 (Table 5). No differences were observed in cleavage rates. However, 
blastocyst rates were significantly depressed by 25 µM CLA t10, c12 
supplementation. Then, the lipid content of d-8 embryos was determined by 
epifluorescence microscopy after Nile red staining (Figure 3). Lipid content was 
increased by the CLA t10, c12 isomer when compared to the control group (P < 0.05), 
and treatment with CLA c9, t11 had a significant effect only when provided at 25 µM. 
Relative expression of the survivin gene was depressed by 15 and 25 µM of CLA t10, 
c12 and by 15 µM CLA c9, t11 (Figure 4). Expression of HSP 70.1 was decreased 
only by CLA t10, c12 at 15 µM. 
Experiment 3: Effect of low-dose CLA supplementation during maturation only or 
throughout the entire embryo production process. 
Supplementation of CLA isomers at different points throughout the embryo 
production process did not affect cleavage rates among groups (P > 0.05; Table 6). 
However, blastocyst rates were depressed when CLA t10, c12 was supplemented both 
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during IVM and during the post-IVF culture period. CLA c9, t11 only affected 
blastocyst rate when provided at IVC. Blastomere counts (Figure 5) did not differ 
among groups treated with 15 µM of either CLA isomer (P > 0.05). 
Experiment 4: Effect of CLA supplementation on embryo viability following 
vitrification and thawing. 
Although there was some variation in embryo cleavage rates among groups, 
overall percentages were within an acceptable range (86 to 95%; Table 7). Analyses 
for blastocyst survival rates showed that treatment with 100 μM of CLA c9, t11 during 
IVC prior to vitrification performed the best among all the vitrified groups, but was 
not statistically different from control or CLA t10, c12 100 μM IVC. Treatment levels 
t10, c12 CLA 15 μM IVM and c9, t11 CLA 15 μM IVM yielded the lowest survival 
values (less than 20%; Table 7). Analyses of blastomere cell counts showed that 
embryos treated with 100 μM c9, t11 CLA prior to vitrification had the highest 
blastomere count among all the vitrified groups (P < 0.01; Figure 6) with cell count 
comparable (P > 0.05) to that in non-vitrified control embryos (Control+).  
DISCUSSION 
Previous reports have shown that CLA isomers, as other PUFAs, affect lipid 
configuration and membrane integrity along with cell signaling (Fouladi-Nashta et al., 
2009; Marei et al., 2009; Al Darwich et al., 2010). Hence the beneficial effects of 
CLA during culture and on survival of embryos following cryopreservation have been 
explored (Pereira at al., 2007; Pereira et al., 2008). However, the effect of CLA 
isomers on bovine oocytes and embryos in the context of oocyte maturation and 
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embryo development to blastocysts requires further investigation (Lapa et al., 2011). 
The main objective of the current study was to systematically assess the effect of CLA 
supplementation at different stages during the in vitro embryo production process on 
maturation, cleavage and preimplantation blastocyst development.  
In the first experiment, in which we performed parthenogenetic activation of 
oocytes, CLA supplementation during IVM had no effect on maturation, cleavage or 
blastocyst rates. However, when CLAs were supplemented at high doses during the 
entire culture period, we observed significant differences in maturation and cleavage 
rates which were generally negative and dose dependent. Subsequent trials with low 
CLA concentrations showed neither statistically significant differences nor benefits of 
supplementation on embryo development after parthenogenetic activation.  Across this 
experiment, 15-100 μM CLA t10, c12 increased cleavage rates without concomitant 
increases in blastocyst rates, a result for which we do not have a reasonable 
explanation.  
Previous studies have shown that PUFAs play a role in follicular cell 
steroidogenesis. Indeed, a study of the effect of PUFAs upon granulosa and theca cells 
in culture showed that fatty acid supplementation increased P4 production in theca 
cells (Hughes et al., 2011). Contradictory effects of progesterone on oocyte and 
embryo developmental competence have been reported (Fair and Lonegan, 2012). For 
example, one study indicated a detrimental effect of progesterone on in vitro matured 
oocytes (Fukui et al., 1982) contrasting with others reporting a beneficial effect of 
progesterone during embryo culture (Pereira et al., 2009; Fergusson et al., 2012). In 
the current study, addition of CLAs during IVM upregulated progesterone levels in a 
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dose dependent manner, which in turn was inversely correlated to embryo 
development. The fact that progesterone was upregulated by the effects of CLA upon 
cumulus cells (enclosing the oocytes), is interesting because this granulosa cell 
phenotype, to our knowledge, has not been reported. Given that the oocyte and 
cumulus cells are considered a complex, we suggest that CLAs exerted a global effect 
upon COCs. In this regard, one potential explanation may be that CLAs affect 
signaling transducers such as Sma and Mad-related (SMAD) intracellular signal 
transducers that are present in the cumulus cells thereby altering sterol synthesis 
(Gilchrist, 2011). Alternatively, CLAs may have affected the morphogenetic gradient 
generated by oocyte secreted factors that in turn maintain cumulus cell phenotype and 
other functions related to sterol synthesis (Gilchrist, 2011). 
Given that high CLA doses exerted detrimental effects on parthenogenetic 
embryos in experiment one, we decided to test the effects of CLA supplementation 
upon IVF-produced embryos using low CLA supplemental doses. Results of the IVF 
experiments were overall consistent with those obtained with parthenotes. For 
instance, supplementation with low dose CLA isomers throughout the in vitro embryo 
production process yielded no significant differences in terms of cleavage rates and 
only minor differences in blastocyst rates. However, concentrations higher than 15 μM 
CLA resulted in a significant reduction in blastocyst rates, particularly when using the 
CLA t10, c12 isomer. Although we observed lower blastocyst rates for both CLA 
isomers when used during either IVM or IVC when compared to control, CLA c9, t11 
at both concentrations tested yielded higher values than with CLA t10, c12. In this 
regard, a consistent observation throughout our study was that long term CLA 
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supplementation, especially with the higher doses, was detrimental to embryos. These 
findings are in agreement with Hughes et al. (2011) who found long term culture in 
the presence of PUFAs resulted in poorer quality embryos. In addition, PUFAs may 
affect the stearoyl-CoA desaturase (Scd) gene that in turn has direct effects on 
membrane fluidity and lipid metabolism (Keating et al., 2006). However, further 
experiments need to be performed to confirm this hypothesis.  
Al Darwich et al. (2010) showed that relative gene expression of lipogenic 
transcription factors such as SREBP1 and Scd were numerically higher in embryos 
treated with 100 μM t10, c12. In this regard, results from the Nile red staining 
experiment were consistent with CLA t10, c12 yielding a higher epifluorescent signal 
for lipid content. Based upon the work of Granlund et al. (2005), we speculate that a 
glucose transporter could be affected by CLA t10, c12 thus exerting its effects on 
lipogenic transcription factors such as LXRα. Besides being involved in its own 
upregulation, LXRα is involved in the regulation of other lipogenic genes such as 
SREBP1 and FAS. It was obvious that embryos treated with ≥ 25 μM CLA t10,c12 
appeared less viable quantitatively (i.e. reduced blastocyst and survival rates) and, 
more importantly, qualitatively (i.e. reduced blastomere cell counts). Alternatively, 
CLA t10, c12 may have redirected glucose toward the triglyceride synthesis pathway, 
thus compromising glycolysis, a pathway that is physiologically enhanced during 
morula compaction. If this is true, the redirection of glucose fate and the alteration in 
lipogenesis may have been detrimental for embryos, and further aggravated by lower 
metabolism of internal lipids due to the lack of L-carnitine in vitro (Sutton-McDowall 
et al., 2012).The relative transcript abundance of two anti-apoptotic markers whose 
 85 
expression is related to embryo survival (survivin and HSP 70.1) was reduced at both 
CLA t10, c12 concentrations whereas supplementation with c9, t11 CLA seemed to 
maintain a similar relative expression to that in the control group. With this body of 
evidence we report that CLA t10, c12 was consistently detrimental not only upon 
blastocyst rates, but also upon the developmental performance as evidenced by 
qualitative markers.  
Cytoplasmic lipid content of bovine oocytes/embryos and other species such as 
equine, swine and canine, is physiologically higher than that in the human and murine 
species (Sturmey et al., 2009). However, recent evidence indicates that high levels of 
fatty acids disturb mitochondrial activity during in vitro maturation (van Hoeck et al., 
2013). In addition, excessive lipid accumulation may affect the developmental 
performance of embryos undergoing cryopreservation procedures. For that reason we 
tested the ability of embryos to survive cryopreservation following supplementation 
with either the low 15 μM CLA dose or under a higher 100 μM dose for a short time 
period as tested in previous studies (Pereira et al., 2007; Al Darwich et al., 2010). In 
our study, embryos obtained from IVM supplemented with 15 μM CLAs had poorer 
survival rates after thawing. However, short incubation with CLAs from the morula to 
early blastocyst stage, especially for isomer c9, t11 resulted in higher survival rates as 
compared to the control group that underwent vitrification. Furthermore, while our 
results appear to contradict those from previous studies (Pereira et al., 2007, 2008)  
regarding embryo development and performance after vitrification, 100 μM isomer 
c9,t11 supplemented for 36 hr prior to vitrification resulted in similar blastomere 
counts to our quality control group not undergoing vitrification. This finding supports 
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the notion that during the short incubation period, supplementation with this CLA 
isomer exerted beneficial effects through improved membrane fluidity (Zeron et al., 
2002).  
CONCLUSION 
Through a systematic series of experiments, we studied the effect of CLA 
isomers during the in vitro embryo production process of parthenogenetically 
activated or in vitro fertilization embryos up to d-8 post activation or post fertilization 
stage, respectively. Overall, the effects of CLA on embryo development and 
performance were detrimental especially for isomer t10, c12 and for longer periods of 
culture. Embryos supplemented with CLA c9, t11 100 μM during a short incubation 
time (36 hr) showed the highest survival rates and blastomere cell counts. Additional 
benefits from CLAs supplementation, other than better performance after thawing 
vitrified embryos, require further study.  
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TABLES 
 
Table 1. Primers used for embryo RNA transcript quantification. 
 
Name Primer sequence (5’ -> 3’) Fragment size (bp) Temp. (
oC) Reference 
RPS9 Forward CCTCGACCAAGAGCTGAAG 62 60 Janovick-Guretzky et al. (2007) RPS9 Reverse CCTCCAGACCTCACGTTTGTTC 
Survivin Forward CATTCATCCGGTTGTGCTTTCC 175 55 Rizos et al. (2004) Survivin Reverse GCTGCTCAATGGCACAGCGGAC 
Hsp 70.1 Forward CCCCAAGCTATGTCGCCTT 239 60 Rief et al. (2002) Hsp 70.1 Reverse GGATTCATTGCGACTTGGTT 
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Table 2. Effects of high dose CLA supplementation in maturation medium upon 
parthenogenetically activated embryo development (Experiment 1). 
 
Group Total oocytes* 
Maturation 
rate*(%) 
Cleavage 
rate*(%) 
Blastocyst rate*1 
(%) 
Control 35.0 ± 3.0 94.0 ± 2.0 83.7 ± 2.5 31.5 ± 6.2 
t10 c12 50 μM  35.7 ± 2.7 90.9 ± 5.1 81.6 ± 6.2 25.2 ± 8.1 
t10 c12 100 μM  35.3 ± 0.3 90.5 ± 2.6 80.2 ± 6.6 29.5 ± 1.3 
t10 c12 200 μM  35.3 ± 2.0 88.9 ± 2.5 76.3 ± 7.7 33.4 ± 10.5 
c9 t11 50 μM  34.7 ± 1.9 93.3 ± 0.7 85.4 ± 4.3 22.9 ± 4.7 
c9 t11 100 μM  35.0 ± 1.0 94.2 ± 2.9 86.3 ± 6.8 28.5 ± 7.0 
c9 t11 200 μM  35.0 ± 0.6 89.6 ± 1.7 78.3 ± 3.5 31.1 ± 9.1 
 
*mean ± SEM from 3 replicates. Means within columns were not significantly different. 
1blastocyst rates were based on percentages of the original oocyte number. 
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Table 3. Effects of high dose CLA supplementation during the entire culture period (pre- 
and post-activation) upon parthenogenetically activated embryo development 
(Experiment 1). 
 
Group Total oocytes* 
Maturation 
rate*(%) 
Cleavage 
rate*(%) 
Blastocyst 
rate*1(%) 
Control 35.7 ± 1.1 94.4 ± 1.5abc  76.2 ± 2.6bc 28.0 ± 4.2a 
t10 c12 50 μM  35.7 ± 1.1 97.1 ± 1.1a 87.2 ± 2.8a 17.9 ± 1.8bc 
t10 c12 100 μM  36.2 ± 1.1 95.4 ± 1.0ab 80.9 ± 2.2ab 11.5 ± 2.1cd 
t10 c12 200 μM  37.0 ± 2.5 90.1 ± 1.5d 76.1 ± 3.4bc 07.8 ± 0.9d 
c9 t11 50 μM  35.8 ± 1.4 91.2 ± 1.6cd 71.5 ± 3.9c 23.3 ± 2.2ab 
c9 t11 100 μM  35.3 ± 1.6 91.3 ± 1.6cd 77.1 ± 3.4bc 16.4 ± 1.5c 
c9 t11 200 μM  36.7 ± 1.5 92.2 ± 1.2bcd 80.6 ± 3.8abc 15.2 ± 1.2c 
 
*mean ± SEM from 6 replicates. Means within a column not sharing the same letter are 
significantly different (P < 0.05). 
1blastocyst rates were based on percentages of the original oocyte number. 
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Table 4. Effects of low dose CLA supplementation during the entire culture period (pre- 
and post-activation) on parthenogenetically activated embryo development (Experiment 
1). 
 
Group Total oocytes* 
Maturation 
rate*(%) 
Cleavage 
rate*(%) 
Blastocyst 
rate*1(%) 
Control 34.2 ± 1.0 89.0 ± 1.2 67.7 ± 2.8cd 20.7 ± 1.9 
t10 c12 15 μM  35.2 ± 1.6 94.5 ± 1.8 86.6 ± 2.0a 19.4 ± 1.0 
t10 c12 25 μM  33.8 ± 0.6 93.0 ± 2.4 75.5 ± 3.2abcd 18.7 ± 4.7 
t10 c12 50 μM  34.6 ± 1.4 91.4 ± 2.9 78.8 ± 6.1abc 14.2 ± 1.0 
c9 t11 15 μM  33.6 ± 1.4 92.7 ± 2.4 79.2 ± 4.1ab 17.9 ± 3.2 
c9 t11 25 μM  35.0 ± 1.1 92.0 ± 1.6 69.9 ± 3.8bcd 18.7 ± 1.9 
c9 t11 50 μM  34.8 ± 2.0 91.1 ± 1.5 64.3 ± 3.7d 19.3 ± 2.1 
 
Means within a column not sharing the same letter are significantly different (P < 0.05). 
*mean ± SEM from 5 replicates. 
1blastocyst rates were based on percentages of the original oocyte number. 
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Table 5. Effects of low dose CLA supplementation throughout culture 
on production of embryos by in vitro fertilization (Experiment 2).  
 
Group Total oocytes* Cleavage rate*(%) 
Blastocyst 
rate*1 (%) 
Control 40.5 ± 1.6 86.9 ± 1.5 38.2 ± 2.3a 
t10 c12 15 μM  42.5 ± 1.8 89.6 ± 1.8 36.6 ± 4.8a 
t10 c12 25 μM  42.8 ± 1.7 82.4 ± 3.0 25.5 ± 2.1b 
c9 t11 15 μM  42.3 ± 2.0 83.8 ± 1.9 38.2 ± 2.3a 
c9 t11 25 μM  41.8 ± 1.5 82.1 ± 3.9 32.9 ± 2.4ab 
 
*mean ± SEM from 4 replicates. Means within a column not sharing the 
same letter are significantly different (P < 0.05). 
1blastocyst rates were based on percentages of the original oocyte 
number. 
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Table 6. Effects of low dose CLA supplementation during in vitro maturation 
(IVM) or throughout the entire in vitro embryo production (IVC) period 
(Experiment 3). 
 
Group Total oocytes* Cleavage rate*(%) 
Blastocyst 
rate*1(%) 
Control 45.3 ± 1.9 90.1 ± 0.2 34.18 ± 1.2a 
t10 c12 15 μM IVM 44.8 ± 2.8 92.3 ± 1.0 28.61 ± 1.2b 
t10 c12 15 μM IVC 44.5 ± 2.6 87.1 ± 3.2 20.55 ± 2.4c 
c9 t11 15 μM IVM 45.0 ± 2.3 88.4 ± 2.4 33.97 ± 1.6a 
c9 t11 15 μM IVC 46.0 ± 3.0 90.2 ± 1.1 27.65 ± 1.2b 
 
*mean ± SEM from 4 replicates. Means within a column not sharing the same 
letter are significantly different (P < 0.05). 
1blastocyst rates were based on percentages of the original oocyte number. 
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Table 7. The effect of CLA supplementation during in vitro maturation of oocytes (IVM) 
or embryo culture (IVC) on embryo viability following vitrification (Experiment 4). 
 
Group Total oocytes* 
Cleavage 
rate*(%) Embryos (n)
* Survival rate*1(%) 
Control 42.0 ± 0.0 90.5 ± 2.3ab 30.5 ± 0.7 39.24 ± 4.7ab 
Control +2  43.5 ± 0.5 95.4 ± 2.2a NA NA 
t10 c12 15 μM IVM3 42.5 ± 0.5 92.9 ± 0.1a 30.5 ± 2.1 05.26 ± 1.4c 
t10 c12 100 μM IVC4 40.0 ± 2.0 86.3 ± 0.5b 31.5 ± 0.7 30.41 ± 1.8ab 
c9 t11 15 μM IVM3 42.5 ± 0.5 90.6 ± 0.1ab 32.5 ± 0.7 21.63 ± 9.1bc 
c9 t11 100 μM IVC4 40.5 ± 0.5 86.4 ± 1.4b 27.5 ± 3.5 44.36 ± 5.6a 
 
*mean ± SEM from 2 replicates. Means within a column not sharing the same letter are 
significantly different (P < 0.05). 
1Survival rates were based on the numbers of vitrified embryos. 
2Group not undergoing vitrification, blastocysts were used for blastomere cell counts. 
3CLAs supplemented only at IVM. The remainder of the culture period was performed with 
CLA-free medium. 
4CLAs supplemented on d-5 post fertilization embryos for a period of 36 hours. 
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FIGURES 
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Figure 1. Effect of high doses of CLA isomers during oocyte maturation on progesterone 
concentrations in maturation medium (Experiment 1). 
Means ± SEM not sharing the same letter are significantly different (P < 0.05). 
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Figure 2. Effect of low dose CLA-isomer supplementation during oocyte maturation 
upon progesterone concentrations in the medium (Experiment 1). 
Means ± SEM not sharing the same letter are significantly different (P < 0.05). 
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Figure 3. Effect of CLA supplementation on lipid content in d-8 IVF embryos.  
(a) Nile red staining technique (Bonilla and Hansen 2009) was used to measure differences among groups. Means not 
sharing the same letter are significantly different (P < 0.05). Each error bar represents 1 standard error of the mean. (b) 
Representative embryo stained with Nile red at d-8 post insemination.  
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(b)                   (a) 
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Figure 4. Effect of CLA supplementation on gene expression in d-8 bovine IVF embryos. 
HSP 70.1 (solid bars) and Survivin (open bars). Values represent means ± SEM (n=13 ± 4 
embryos per group per replicate) with statistical differences (P < 0.05) from control indicated 
by different superscripts.  
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Figure 5. Effect of CLA supplementation (15 μM) during in vitro oocyte (IVM) or throughout 
culture (IVC) on blastomere counts at d-8 post fertilization.  
Blastocyst cell numbers (a) are presented as mean ± SEM. No statistical differences (P > 0.05) were 
detected. (b) Blastomere count was determined by staining the embryos with Hoechst 33342 (n = 66 
embryos) and counting under an epifluorescent microscope at 40X. 
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Figure 6. Effect of CLA supplementation at different time points. 
15 μM at in vitro maturation or 100 μM at in vitro embryo culture were supplied during the in vitro 
preimplantation embryo production for mean blastomere counts at post survival assessment 
(equivalent to d-8 post fertilization. Mean ± SEM blastocyst cell numbers not sharing the same letter 
are significantly different (P < 0.05). Blastomere count was determined by staining the embryos (n = 
80) with Hoechst 33342. Control + embryos did not undergo vitrification. 
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CHAPTER FOUR: ENHANCING GLUCOSE METABOLISM OF BOVINE 
EMBRYOS IN VITRO IN PREPARATION FOR THE HYPOOXYGENATED 
UTERINE ENVIRONMENT. 
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ABSTRACT 
 
Metabolic regulators (MR) such as 2, 4—dinitrophenol (DNP) and phenazine 
ethosulfate (PES) can improve glucose metabolism of bovine embryos in vitro via two 
different pathways viz. glycolysis and pentose phosphate pathways. These metabolic 
enhancers are intended to stimulate the metabolic switch from low to high glucose 
utilization at the morula stage. This metabolic adjustment occurs naturally along the 
oviduct during migration of the preimplantation embryo toward the hypooxygenated 
environment of the uterus. The objectives of this study were to evaluate the effects of 
these MR, individually or in combination, on development of bovine embryos 
obtained by in vitro fertilization procedures. Further, the effects of MR in combination 
with a conjugated linoleic acid isomer (CLA—cis9, trans11) were evaluated on 
viability of embryos after vitrification. In Experiment 1, embryos were supplemented 
with PES (0.3 μM), DNP (10 μM), the combination and Control. In Experiment 2, 
embryos were supplemented with lower PES (0.15 μM) in combination with DNP at 3 
doses (5, 10 and 30 μM). Two quality control groups were included: one group 
remained untreated and the other was the combined MR treatment from Experiment 1 
(PES 0.3 μM + DNP 10 μM). Experiment 3 consisted of 4 treatment groups. The best 
treatment from Experiments 1 and 2 (DNP 10 μM, PES 0.3 μM) was supplemented 
with 0, 50, or 100 μM CLA cis9, trans11 on day 7 for the subsequent 36 hours before 
vitrification. In addition, one control group remained MR and CLA-free. In 
Experiment 1 and 2, blastocyst rates significantly increased from using the 
combination of MR (DNP 10 μM, PES 0.3 μM; control +) as compared to control and 
other treatment combinations (> 40% vs. ~30%; P < 0.05). The best MR combination 
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resulted in expanded-stage blastocyst rates higher than control (28% vs 15%; P < 
0.05). MR resulted in a marked dose-dependent effect on the triglyceride content of 
expanded stage embryos (P < 0.05) and had a positive effect in blastomere number of 
expanded embryos (P < 0.05). Treatment with PES alone negatively affected average 
blastomere numbers (126) when compared to other groups (DNP = 148; combination 
= 142) including control (135). In Experiment 3, MR treated embryos resulted in 
higher re-expansion rates after embryos were thawed when compared to control (71% 
vs. 60%, respectively). In addition, CLA treated embryos showed the lowest re-
expansion rates and this effect was more evident with the highest CLA dose (CLA 50 
μM = 51%, CLA 100 μM =32%). Among all treatment groups, vitrified embryos 
showed no differences in terms of cytoskeleton integrity post-thaw. In conclusion, 
addition of MR improved blastocyst rates, but most importantly expanded stage 
embryo rates were about 2-fold higher when compared to control. Following MR 
alone, embryos showed high capability to withstand the stressful procedures of 
vitrification and were similar to vitrified control group. Treatment with CLA did not 
provide any further additive effect on blastocyst rates nor on benefits after 
vitrification.  
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INTRODUCTION 
 
Soon after fertilization in vivo, the developing embryo is exposed to a dynamic 
environment as its metabolism changes from early to late preimplantation stages. 
Pyruvate and lactate are the preferred energy substrates during precompaction stages, 
coincident with location in the relatively well oxygenated environment of the oviduct. 
As the embryo reaches the uterus, usually at compacted morula or early blastocyst 
stages, the local oxygen tension decreases and glucose metabolism is enhanced to 
accommodate the higher demands for energy (Thompson et al., 2000). This metabolic 
switch from low to high glucose consumption would likely seem of equal importance 
in vitro to ensure an optimal environment for development prior to transfer of embryos 
to recipients.  
One of the problems researchers faced earlier was the effect of glucose in 
media formulation at precompaction stages and the undesirable early onset of 
glycolysis resulted in embryo growth retardation or embryo development block 
(reviewed by Thompson, 2000; Ménézo et al., 2013). The adverse effect is reported to 
occur at the level of the rate limiting hexokinase that is alosterically regulated by 
substrate preference of the aforementioned tricarboxylic acids (Gardner et al., 2013). 
However, the discovery of supplementing the culture media with 
ethylenediaminetetraacetic acid (EDTA) overcame the embryo development block 
through inhibition of the so called “Crabtree-effect” and consequently, embryos were 
able to continue further cell cycles (Thompson et al., 2000). After the problem of early 
onset of glycolysis was solved by the addition of EDTA, it was acknowledged that 
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glucose metabolism needed to be enhanced at postcompaction stages. The use of 
chemicals with the opposite effect of EDTA has been demonstrated not only to 
enhance glucose consumption, but also to improve embryonic development and 
competence. On the one hand, the use of oxidative phosphorylation uncouplers such as 
2,4—dinitrophenol (DNP) has been demonstrated to partially inhibit oxidative 
phosphorylation while enhancing glycolysis (Thompson et al., 2000). Although the 
exact mechanism of DNP remains to be elucidated, those authors proposed that partial 
inhibition of mitochondrial oxidative phosphorylation regulates the relative 
contribution of glycolytic ATP and overall favors glucose metabolism. On the other 
hand, phenazine ethosulfate (PES) acts as an electron acceptor for reduced 
nicotinamide adenine dinucleotide phosphate (NADPH) during oxidization to NADP. 
Thereby, PES enhances the pentose phosphate pathway and the conversion of glucose-
6-phosphate to 6-phosphogluconate (De La Torre Sanchez et al., 2006).  
Excessive lipid droplet formation is widely acknowledged to occur in embryos 
produced in vitro. There is a current interest in defining protocols that would reduce 
excessive cytoplasmic lipid droplet formation in this type of embryos, especially for 
those undergoing cryopreservation procedures. Polyunsaturated fatty acids, including 
conjugated linoleic acids isomers (CLA), can alter lipid membrane configuration and 
provide protection during cryopreservation procedures (Pereira et al., 2008; Marei et 
al., 2009). Our previous work indicated that inclusion of CLA (100 μM cis9, trans11) 
before vitrification improved post-thaw survival and embryo development (Absalón-
Medina et al., 2011; Chapter Three). However, CLA was added from morula to early 
blastocyst stages, i.e. from d 5 to d 6.5 post IVF. For practical purposes we decided to 
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work with later stage embryos (7.5 d-post IVF), the embryonic stage routinely used for 
IVF embryo transfers. Furthermore, it has been reported that addition of PES to 
embryo culture media inhibits fatty acid synthesis in embryos (Sudano et al., 2011) 
and provided an important reason for testing the effects of PES in combination with 
DNP and CLA prior to vitrification procedures. 
Since DNP and PES both stimulate the metabolism of glucose, but via two 
different metabolic pathways, the objectives of this study were to evaluate the effect of 
both chemicals, individually and in combination, on the rate of bovine embryo 
development. In addition, we evaluated the effects of these metabolic regulators in 
combination with CLA cis9, trans11 to observe the effects on triglyceride content and 
post thaw survival rates of vitrified embryos. 
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MATERIALS AND METHODS 
Chemicals and Reagents 
All chemicals and reagents were obtained from Sigma-Aldrich Co. (Saint Louis, MO, 
USA), unless otherwise indicated.  
Experimental design 
The effects of PES and DNP supplementation on bovine embryos. 
In 8 replications, the media of bovine embryos was supplemented with PES 
(0.3 μM), DNP (10 μM) and the combination. Metabolic regulators were supplied 
from d 5 to d 8 post insemination. Embryos were stained and examined under 
epifluorescent microscopy for total embryo cell count and triglyceride content to 
assess embryo development and quality. For this we used only embryos at a 
homogenous developmental stage, i.e. expanded embryos (d-8 post insemination). A 
total of 1,249 COCs were used for this experiment. 
The effects of the combination of low PES and varied concentrations of DNP on 
bovine embryos. 
In 6 replications, bovine embryo media was supplemented with PES (0.15 μM) 
in combination with DNP at three levels (5, 10 and 30 μM). In addition, two quality 
control groups were included: One group remained untreated (negative control) and 
the other was the combination of PES 0.3 μM and DNP 10 μM from Experiment 1 
(positive control). Metabolic regulators were supplied from d 5 to d 8 post 
insemination. Differential staining under epifluorescent microscopy was used to 
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determine total embryo cell count and triglyceride content as in experiment 1. A total 
of 1,247 COCs were used in this experiment. 
The effects of metabolic regulators in combination with CLA cis9, trans11 on post- 
thaw viability of vitrified embryos. 
This experiment consisted of the best treatment from  the previous trials (PES 
[0.3 μM] and DNP [10 μM)]) in combination with 0, 50, or 100 μM CLA cis9, trans11 
(4 treatment groups with three replicates). The Control group remained free of the 
metabolic regulators and CLA. The CLA was added at d-6 post fertilization for 36 hrs. 
Embryos were vitrified using a commercial vitrification kit (BoviPRO Vit KitTM from 
Minitube) at d-7.5 post insemination (only expanded blastocyst stage). We measured 
post-thaw blastocyst re-expansion rates, total blastomere count and cytoskeleton 
integrity (vide staining procedures). A total of 620 COCs were used for this 
experiment. 
Oocyte recovery and selection 
Bovine ovaries were collected at a nearby abattoir (120 km) and transported to 
the laboratory in prewarmed lactated Ringer’s solution at 30-35 °C. Cumulus oocyte-
complexes (COCs) from 2-8 mm follicles were aspirated with an 18G hypodermic 
needle attached to an aspiration pump unit adjusted to a flow of 22.5 ± 2.5 ml of H2O 
per minute. Follicular fluid supernatant was removed and the pellet containing COCs 
was transferred to a 15 ml tube where it was resuspended with holding media and the 
contents were poured gently into a 100 mm Petri dish. Holding media consisted of 
TCM-199 Hank’s salts (Invitrogen, Grand Island, NY), 10% Fetal Calf Serum (FCS; 
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Invitrogen), 25 μg/ml of gentamicin, 0.2 mM Na-pyruvate, and heparin 5 μg/ml with a 
mOsm = 300 ± 1. Selection of COCs was based on morphological assessment as 
having several layers of cumulus granulosa cells and oocytes with a homogenous 
cytoplasm. The entire process was performed within 5 hr including transportation. 
In vitro pre-maturation 
Following the method of Albuz et al. (2010), selected COCs were pre-matured 
in holding media (vide supra) supplemented with adenylate cyclase activator, 
forskolin, and IBMX, a non-specific phosphodiesterase (PDE) inhibitor, at a final 
concentration of 100 μM and 500 μM, respectively, in order to increase overall cAMP 
levels and to inhibit overall PDEs in both cumulus cells and oocytes. Millimolar stock 
concentrations of the chemicals were stored at -20 °C dissolved in dimethylsulphoxide 
(DMSO) and used fresh in each trial. In groups of about 40 COCs, pre-maturation 
treatment was carried out under atmospheric and humidified conditions at 38.5 °C for 
2 hr. 
In vitro Maturation 
Selected COCs were matured in groups of 40 ± 5 for 30 hours in 400 μL of 
TCM-199 (Earle’s Salts) enriched with 10% FCS, 0.2 mM sodium pyruvate, 1 mM 
alanyl-glutamine, 0.1 mM taurine, 0.1 mM cysteamine, 1 μg/ml estradiol, 85 mU/ml 
bovine follicle stimulating hormone (FSH, SIOUX Biochemical, Inc., Sioux Center, 
IA), 20 μg/ml gentamicin, at pH 7.35 ± 0.02 and mOsm 300 ± 2 and covered with 
light mineral oil in a humidified atmosphere at 38.5 °C with 5% CO2 in air. In 
addition, based on Albuz et al. (2010), COCs were cultured during the entire 
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maturation process with a type 3-specific PDE inhibitor, cilostamide (20 μM; Biomol, 
Plymouth Meeting, PA, USA). 
In vitro fertilization 
After a total of 30 hours, presumptive matured oocytes were transferred to a 
modified IVF medium (Fert-TALP; Parrish et al., 1988) supplemented with 0.5 mM 
fructose, 0.2 mM non-essential amino acids, 6 mg/ml BSA FFA Fraction V, 30 μM 
penicillamine, 15 μM hypotaurine, 1.5 μM epinephrine (PHE), 22 μg/ml heparin, 20 
μg/ml gentamicin, covered with light mineral oil in a humidified atmosphere at 38.5 
°C with 5% CO2 in air for 18 hr (pH of 7.38 ± 0.01, mOsm 285 ± 1). Frozen semen 
straws (Genex, Ithaca NY, USA) from a single bull and from the same ejaculate were 
thawed at 37 °C for 30 sec. Motile sperm were separated from cryoprotectant, non-
motile sperm, and debris by Percoll® double density gradient (90% and 45%) 
centrifugation at 300 x g for 20 min. Subsequently, sperm were washed twice in 5 ml 
of TL-Semen (pH 7.39 ± 0.01, mOsm 295 ± 2), which is a modified Tyrode’s from 
Parrish et al. (1989) and centrifuged at 300 x g for 5 min to remove Percoll. Finally, 
sperm were adjusted to a final concentration of 1.5 x 106 sperm/ml using Fert-TALP 
media and applied to the oocytes. 
In vitro embryo culture 
A modified synthetic oviductal fluid (SOF) sequential medium  was used (20 
μg/ml gentamicin, pH 7.4 ± 0.01, mOsm 275 ± 5, humidified atmosphere at 38.5 °C 
with 5% CO2, 7% O2, and 88% N2 [Holm et al., 1999]). After fertilization, putative 
zygotes were denuded at maximum vortex speed for 120 sec and transferred to a 
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modified SOF (SOFearly) supplemented with 10 μM EDTA, 0.5 mM fructose, 0.4 % 
(w/v) BSA FFA Fraction V, 0.1 mM taurine, 10 ng/ml epidermal growth factor (EGF; 
BD Biosciences—Discovery Labware, MA), without essential amino acids, and 
covered with light mineral oil for ~48 hr. Thereafter, cleavage rates were assessed and 
embryos were transferred to new droplets containing SOFmid1, with essential and non 
essential amino acids, 0.4 % (w/v) BSA FFA Fraction V, 1.0 mM glucose, 10 ng/ml 
EGF, 100 μM β mercapto ethanol (β-ME), 1 μM EDTA and 1 ng/ml progesterone (P4) 
for ~48 hours. Embryos were transferred to fresh SOFmid2 droplets, which consists of 
SOFmid1 but supplemented with 1.5 mM glucose, under the same conditions for 
another ~48 hours. Finally, d-7 embryos were transferred for the last ~ 24 hours of 
culture to SOFlate, which is SOF supplemented with 5% (v/v) FCS, 0.1 mM taurine, 10 
ng/ml EGF, 1 ng/ml P4 and 2.0 mM glucose. 
Staining procedures 
All incubations and washing steps were accomplished in 96-well dishes. 
Embryos were washed three times in 1x PBS supplemented with 0.1% PVP before 
transfer to the fixative solution. Embryos were fixed in 4% paraformaldehyde 
overnight at 4 °C. Subsequently, embryos were washed 3 times in PBS/PVP solution 
and incubated with the corresponding dye as follows. For neutral lipid staining, Nile 
red (Invitrogen, Molecular probes) was used at a concentration of 5 μg/ml of 
PBS/PVP and incubated at room temperature for 30 min in the dark. For cytoskeleton 
staining, the procedures and classification were based on Makarevich et al. (2011). 
Briefly, embryos were incubated overnight in a PBS/PVP solution supplemented with 
  116 
0.1% Triton x-100 and stained with rodhamine phalloidin that selectively binds to 
Actin filaments (Invitrogen, Molecular probes) at a 1:20 dilution in PBS/PVP at room 
temperature for 30 min in the dark. Grade 1= F-Actin reticulated-well defined bands, 
grade 2= F-Actin bands fairly visible and grade 3= F-Actin bands poorly defined. For 
blastomere count, embryos were incubated in a PBS/PVP solution containing 10 
μg/ml of Hoechst 33258 for 15 min at room temperature in the dark. Stained embryos 
were washed 3 times in PBS/PVP to reduce non-specific binding. Embryos were 
mounted on slides with 2 etched 10 mm diameter circles surrounded by white ceramic 
ink and covered with ProLong Gold antifade reagent (Invitrogen, Molecular probes). 
Epifluorescent microscopy  
All slides were visualized using a microscope (Imager Z1; Carl Zeiss, Inc.) 
equipped with 20X 0.5 NA ECPlan Neofluar objective (Carl Zeiss, Inc.). Embryo 
samples were excited at 340 nm, 488 nm and 540 nm and the emitted wave lengths 
were 470 nm, 515 nm and 565 nm to visualize DAPI nuclear stain, neutral lipids (Nile 
red) and cytoskeleton (F-actin), respectively. Images were captured with a cooled 
charged-coupled device camera (AxioCam MRm; Carl Zeiss, Inc.) and processed 
using AxioVision software (version 4.7.2; Carl Zeiss, Inc.).  
BSA:CLA—Complex  
The CLA isomer, cis9, trans11 (> 90% pure), was purchased from Nu-Chek 
Prep., Inc., Elysian MN. The CLA was conjugated to fatty acid-free BSA in a 4:1 ratio 
to prepare 4.5 mM CLA—BSA stocks using a method adapted from Keating et al. 
(2006).  
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Statistical analysis 
One-way analysis of variance (ANOVA) between treatments was performed 
using JMP version 10 (Statistical Discovery from SAS). If replicates were different 
over time, we included replicate in our models as a random variable to control for the 
differences between and within experiments. If the main effect was significant, all 
means were compared using Tukey HSD. A probability of P < 0.05 was considered 
statistically significant and P ≤ 0.1 was considered a trend. Proportional data not being 
normally distributed was arc-sine transformed and results are presented in the tables as 
back transformed data. Likewise, numerical data not being normally distributed was 
transformed to its natural logarithm. For the triglyceride content analyses, average 
pixel intensity from the captured Nile red stain images were obtained using the 
polygon selection tool to measure the whole embryo area (ImageJ 1.44p; Wayne 
Rasband National Institute of Health, USA). In order to assure that differences in 
intensity were from the triglyceride content per se and not due to the size of the 
embryo, we analyzed the differences in only one stage of embryo among experiments 
i.e. expanded stage.  
RESULTS 
The effects of PES and DNP supplementation on bovine embryos. 
The results for this experiment are presented in Table 1; embryo cleavage rates 
were not different among treatments and remained above 80%. For development to 
blastocyst, there was a significant benefit from the combination of both PES and DNP 
as compared to control or treatment with either chemical alone (> 40% vs. ~30%; 
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main effect P = 0.01). Likewise, when the expanded-stage blastocyst rate was 
analyzed, the difference was 2-fold higher (P < 0.01) with the combined treatment 
than control Analyses of neutral lipid status (MPI values, Figure 1) showed a marked 
reduction in triglyceride content with metabolic regulators (main effect P = 0.04). PES 
or DNP alone reduced the triglyceride content by 20%. Total blastomere cell counts 
following treatment with metabolic regulators are illustrated in Figure 2. PES 
treatment resulted in a significantly reduced average number of blastomeres when 
compared to DNP or the combination. Embryonic morphological appearance indicated 
that PES alone resulted in delayed development and yielded blastocysts of reduced 
quality (Figure 3).  
The effects of the combination of low PES and varied concentrations of DNP on 
bovine embryo development. 
Similar to the previous experiment, embryo cleavage rates were not different 
among groups and remained above 80% (Table 2). Combination of DNP at 5 and 30 
μM with PES resulted in numerically higher blastocyst rates (P = 0.06) compared with 
the control group (34 % and 38 % vs. 32 %, respectively). However, the positive 
control (DNP 10 μM, PES 0.3 μM) was consistently higher than the control group and 
values remained similar to the previous experiment (43 %). When blastocyst rates as a 
percentage of morula rates were analyzed, to account for the effect of adding the 
metabolic regulators at this stage, no significant differences were observed and the 
pattern of results remained similar (P = 0.06; Table 2). 
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Addition of metabolic regulators resulted in overall decreased MPI values as 
an indicator of neutral lipid content (main effect P = 0.04). The control group showed 
an MPI of 678 units that is very close to control values in Experiment 1. Embryos 
exposed to PES 0.3 μM and DNP 10 μM (Control +) showed a numerical reduction in 
lipid content by 5.47% when compared to the control group. The  effect of treatment 
with combinations of PES 0.15 μM with DNP 5 to 30 μM was biphasic: a significant 
reduction in MPI of 8.6 % and 10.6 % relative to control for 5 and 10 μM , 
respectively (Figures 4), but the group with PES 0.15 μM and DNP 30 μM was higher 
and not different than the control group. 
There was an overall negative effect on the blastomere number of expanded 
embryos when the higher concentrations of DNP were used (main effect P < 0.01). 
Combinations of PES 0.15 μM with DNP 10 and 30 μM resulted in reduced 
blastomere numbers compared with the cumulative average from control, control + 
and treatment with PES 0.15 μM and DNP 5 μM (99 vs. 121, respectively; Figure 5). 
The effects of PES and DNP in combination with CLA cis9, trans11 on post-thaw 
viability of vitrified embryos. 
Embryo cleavage rates were higher for the control group compared to the other 
treatments (80% vs. 75%; P = 0.03), but morula and total blastocyst rates were not 
significantly different. Comparing blastocyst rates as a percentage of morula rates, 
there was a trend for an effect of metabolic regulators combined as compared with 
other treatments (60% vs. 48%; P = 0.09; Table 3).  
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The effect of metabolic regulators in combination with CLA was tested on 
embryos undergoing vitrification procedures. Amongst all groups, embryos treated 
with metabolic regulators and without CLA resulted in a similar re-expansion rate as 
compared to control embryos after thawing (71% vs. 60%). CLA treated embryos 
showed the lowest re-expansion rates and this effect was more evident with the highest 
CLA dose (CLA 50 μM = 51%, CLA 100 μM =32%; Figure 6). Analyses regarding 
cytoskeleton integrity of the vitrified embryos showed that the distribution of the 
cytoskeleton integrity remained consistent among groups and cytoskeleton integrity of 
most embryos regardless of treatment were grade I and II (Figures 7 and 8). 
Blastomere counts were significantly different across treatment groups compared to 
control (130 ± 5 vs. 114 ± 6; P = 0.03).  
DISCUSSION 
Soon after fertilization, pre-implantation embryos undergo a series of 
metabolic adaptations in vivo in transit to the uterus. These adaptations include 
production of ATP from different substrates according to each of the corresponding 
microenvironments they encounter prior to implantation. Despite the reported inferior 
quality when compared with in vivo derived embryos, in vitro produced embryos 
show a remarkable plasticity for being able to develop in a wide variety of culture 
conditions. In vitro, a population of bovine embryos usually becomes arrested at the 
16-32 cell stage and it has been suggested that this arrest originates by an alteration of 
glucose metabolism (Thompson, 2000). A low to high glucose metabolic switch 
occurs concomitantly as the embryo develops and reaches the morula stage with 
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corresponding metabolic adjustments suitable for a relatively hypoxic environment in 
the uterus. We attempted to circumvent the presumptive metabolic alteration with 
embryos becoming arrested by testing two glucose consumption enhancers that act on 
two different glucose pathways viz. glycolysis and pentose phosphate pathways 
(Thompson et al., 2000; De La Torre-Sanchez et al., 2006). An additive effect was 
observed when the two metabolic regulators where provided simultaneously during 
culture. We observed not only a ~10% increase in the total blastocyst rates, but also 
about twice as many expanded-stage embryos developed by day 8 after fertilization. 
Another benefit from metabolic regulator supplementation was the reduction in 
embryo triglyceride content compared to the control group. Embryos produced in vitro 
are often negatively affected by higher lipid content and, thus, these chemicals may 
provide another advantage to in vitro embryo production. Therefore we continued 
using that particular dose as our positive control for subsequent experiments. Once we 
observed that PES alone yielded lower results, we decided to reduce the dose for the 
subsequent experiments. One particular observation was that only a specific 
combination of MR resulted in beneficial effects. i.e. DNP 10 μM and PES 0.3 μM 
(1:33). When different proportions were used, results were not optimal. These results 
could be interpreted as further enhancing glycolysis by providing more DNP did not 
have a beneficial effect when the pentose phosphate pathway was not also further 
enhanced by PES in a way that glucose could be partitioned adequately. Interestingly 
reduction of triglyceride content in treated embryos with 0.15 μM PES and 5-30 μM 
DNP was biphasic and the highest combined dose of metabolic regulators resulted in 
similar triglyceride content as control. Although, in general, the reduction in 
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triglyceride levels with the metabolic regulators was encouraging, some of those 
embryos showed lower blastomere counts than embryos being supplemented with 
lower doses and control. Nonetheless, we also observed that among all treatments, 10 
μM DNP and 0.3 μM PES yielded more embryos with better morphological 
appearance and this effect was consistent throughout all the experiments. Thus, this 
treatment combination not only improved blastocyst rates, but also improved embryo 
quality. Further, when we used several dose combinations of the metabolic regulators 
we mostly observed reductions in blastomere counts.  
Based on our previous work (Absalón-Medina et al., 2011; Chapter Three) 
with embryo development and vitrification, we decided to follow-up with CLA 
supplementation and used two different doses of CLA, 50 μM and 100 μM, in 
combination with our best MR treatment. Our intention was to move forward and 
supplement CLA at a time relevant for embryo transfers and a more practical approach 
to benefit practitioners and producers using frozen embryos. Surprisingly, after 
vitrification procedures, embryos that were supplemented with CLA showed a 
substantial reduction in re-expansion rates after thawing, although, cytoskeletal 
integrity remained intact. Our data analysis on cytoskeleton integrity, accounting for 
F-Actin filaments staining, showed no substantial differences across all the treatments. 
We do not have a definitive explanation for this phenomenon; however, we suggest 
that CLA affected a mechanism for cyroprotectant-water exchange after thawing. 
Thus, embryos were not able to rehydrate the blastocoel cavity as normally occurs 
during the re-expansion process in expanded-stage blastocysts. We suggest that 
possible disruption of a mechanism of water transport would be most logical. We also 
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speculate that further culture would have provided additional time for those embryos 
to re-expand, but in our study all embryos were fixed immediately after thawing. 
Indeed, Kader et al. (2009) and Shu et al. (2009) reported that vitrified human 
blastocysts are cultured for additional hours in order to provide greater chance for 
rehydration to occur. Our previous report (Absalón-Medina et al., 2011) on CLA 
benefits were observed for embryos treated at the morula to early blastocyst transition 
stage. Therefore, the current expanded-stage embryos were at a different embryonic 
stage than the earlier embryos prior to development of a blastocoel cavity.  
CONCLUSION 
Addition of two metabolic regulators, PES and DNP in combination, showed a 
significant improvement in overall blastocyst rates, but most importantly improved 
expanded stage embryo rates. CLA treatment did not result in a further additive effect 
on embryo rates or in benefits after vitrification procedures and re-expansion rates 
were reduced. However, depending on dose, MR can reduce triglyceride content and 
yield a comparable good performance to withstand the vitrification procedures 
compared with control. Future studies are needed on the use of these metabolic 
regulators in combination with other important media components to emulate the 
natural occurring glucose kinetics in pre-implantation embryos in vitro.  
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TABLES 
 
 
 
 
 
 
 
Table 1. The effects of PES and DNP supplementation on bovine embryos. 
 
Group Total oocytes  Cleavage %  Blastocyst1% Ex blastocyst %  
Control 39.8 ± 0.9 79.7 ± 2.7 31.5 ± 2.7b 15.1 ± 2.3b 
PES (0.3 μM) 38.6 ± 0.9 80.3 ± 2.7 33.8 ± 2.6b 16.7 ± 2.2b 
DNP (10 μM) 38.4 ± 1.0 80.5 ± 2.8 32.2 ± 2.8b 17.5 ± 2.4b 
PES + DNP 39.7 ± 1.1 86.1 ± 3.3 42.8 ± 3.2a 27.9 ± 2.7a 
 
*mean ± SEM from 8 replicates. Means within a column not sharing the same letter 
are significantly different (P < 0.05). 
1Blastocyst and expanded (Ex) blastocyst rates were based on percentages of the 
original oocyte number.
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Table 2. The effects of the combination of low PES and varied concentrations of DNP on bovine embryos. 
 
 Original number of COCs  Original number of morulas 
Group Total oocytes Cleavage % Morula %  Blastocyst
1 % Ex blastocyst
1 
%   Blastocyst
2 % Ex blastocyst
2 
% 
Control 42.3 ± 0.7 80.7 ± 2.9 72.4 ± 3.0 32.0 ± 3.3 15.5 ± 2.9  44.4 ± 3.7 21.41 ± 3.5 
Control + 41.8 ± 0.6 85.5 ± 3.1 77.6 ± 3.3 42.5 ± 3.6 21.8 ± 3.2  54.3 ± 4.1 27.68 ± 3.9 
3One 41.0 ± 0.6 82.3 ± 2.9 73.4 ± 3.0 30.5 ± 3.3 17.5 ± 2.9  41.2 ± 3.7 23.90 ± 3.6 
4Two 41.5 ± 0.7 80.9 ± 2.9 73.3 ± 3.0 34.3 ± 3.3 17.3 ± 2.9  47.5 ± 3.6 24.08 ± 3.5 
5Three 41.5 ± 0.7 84.6 ± 2.9 74.9 ± 3.0 38.2 ± 3.3 21.6 ± 2.9  50.4 ± 3.7 28.32 ± 3.5 
 
*mean ± SEM from 6 replicates. Means within columns were not significantly different. 
1Blastocyst and expanded (Ex) blastocyst rates were based on percentages of the original oocyte number. 
2Blastocyst and expanded (Ex) blastocyst rates were based on percentages of the original morula number. 
3Embryos treated with 0.15 μM PES and 5 μM DNP. 
4Embryos treated with 0.15 μM PES and 10 μM DNP. 
5Embryos treated with 0.15 μM PES and 30 μM DNP.
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Table 3. The effects of metabolic regulators in combination with CLA cis9, trans11 on embryo development. 
 
Group Total 
oocytes 
Cleavage % Morula % Blastocyst1 % Blast2 % Mor  
Control 42.3 ± 1.4 80.7 ± 0.9a 70.6 ± 2.3 33.1 ± 1.9 47.0 ± 2.8 
3MRCLA 50 42.0 ± 1.5 76.9 ± 1.2b 63.1 ± 3.2 31.8 ± 2.6 50.8 ± 3.9 
4MRCLA 100 41.7 ± 1.5 76.8 ± 1.3b 66.4 ± 3.2 31.9 ± 2.6 48.2 ± 3.9 
5Met Reg 40.6 ± 1.6 75.9 ± 1.5b 63.8 ± 3.9 38.4 ± 3.2 60.2 ± 4.7 
 
*mean ± SEM from 3 replicates. Means within a column not sharing the same letter are significantly 
different (P < 0.05). 
1Blastocyst rates were based on percentages of the original oocyte number. 
2Blastocyst rates were based on percentages of the original morula number. 
3Embryos treated with 0.3 μM PES and 10 μM DNP (MR) plus 50 μM CLA. 
4Embryos treated with 0.3 μM PES and 10 μM DNP (MR) plus 100 μM CLA. 
5Embryos treated with 0.3 μM PES and 10 μM DNP. 
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Figure1. The effect of metabolic regulators on triglyceride content (mean pixel intensity, 
MPI).  
PES= 0.3 μM DNP= 10 μM. Means ± SEM not sharing the same letter are significantly 
different. A total of 64 expanded-stage blastocyts were used. 
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Figure 2. The effect of metabolic regulators on embryo blastomere cell count. 
PES= 0.3 μM DNP= 10 μM. Means ± SEM not sharing the same letter are significantly 
different. A total of 66 expanded-stage blastocyts were used. 
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Figure 3. The effect of metabolic regulators on embryo development and quality. 
Panels a, b and c show blastomere nuclei, Nile red-stained lipids and merged images, 
respectively. Panel d = control embryos; Panel e = PES treated embryos; Panel f = 
DNP treated embryos; Panel g = PES+DNP treated embryos in experiment 1.  
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Figure 4. The effect of different concentrations of metabolic regulators on embryo 
triglyceride content (Pixel Intensity (MPI) measurements).  
Control + =PES 0.3 μM, DNP= 10 μM. 
One = PES 0.15 μM, DNP 5 μM 
Two = PES 0.15 μM, DNP 10 μM  
Three = PES 0.15 μM, DNP 30 μM 
Means ± SEM not sharing the same letter are significantly different. A total of 220 
expanded-stage blastocyts were used. 
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Figure 5. The effect of different concentrations of metabolic regulators on embryo 
blastomere cell count. 
Control + =PES 0.3 μM, DNP= 10 μM. 
One = PES 0.15 μM, DNP 5 μM 
Two = PES 0.15 μM, DNP 10 μM  
Three = PES 0.15 μM, DNP 30 μM 
Means ± SEM not sharing the same letter are significantly different. A total of 208 
expanded-stage blastocyts were used. 
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Figure 6. The effect of metabolic regulators and CLA on re-expansion rates post-thaw of 
vitrified expanded stage embryos at day 8 post IVF. 
Control group was vitrified and there was no other treatment. CLA50 or CLA100 
groups= embryos treated with 50 μM or 100 μM CLA + MR. MetReg group= PES 0.3 
μM + DNP 10 μM. Means not sharing the same letter are significantly different. A total 
of 93 embryos were used. 
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Figure 7. The effect of metabolic regulators and CLA on cytoskeleton integrity. 
Among groups, most embryos showed defined F-Actin bands and fell into grade I and II 
categories. There were no statistical differences within categories. A total of 93 embryos 
were used. 
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Figure 8. The effect of metabolic regulators and CLA on embryo quality after 
vitrification procedures.  
This figure shows only grade I (vide Figure 7) F-Actin bands. Panel a shows Control 
group. Panel b shows MetReg group. Panel c shows MR + CLA50 μM group and panel d 
shows MR + CLA100 μM group. Letter alone shows nuclear Hoechst stain. Letter + an 
apostrophe show F-Actin stain and letter + two apostrophes shows the merged image. 
a a’ a’’
b b’ b’’
c c’ c’’
d d’ d’’
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CHAPTER FIVE: COMPARISON OF SEVERAL FRACTIONATION METHODS 
ON SPERM MOTILITY AND IN VITRO BOVINE EMBRYO DEVELOPMENT 
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ABSTRACT 
 The use of in vitro fertilization has been gradually increasing during the past 
decade. It seems likely that, in bovine species, this assisted reproductive technology 
(ART) will be the method of choice in the near future since it has several advantages over 
conventional breeding methods, especially for gender-selected semen. The use of 
colloidal macromolecules in sperm fractionation methods is required for IVF to eliminate 
bad quality sperm and inherent bacterial contamination. The objectives of this study were 
to compare four different colloidal-based sperm separators i.e. Percoll density gradient 
centrifugation (DGC), Old Bovipure single layer centrifugation (SLC), New Bovipure 
(SLC) and Androcoll-B (SLC) on computerized sperm motility parameters and to 
evaluate the effects on in vitro embryo development. The second objective was to 
evaluate the effects of metabolic regulators (MR) in vitro on embryo development of 
gender-selected embryos. 
 Semen purified with New Bovipure and Androcoll-B showed numerically higher 
velocity and linear motility values than the other two treatments, but Androcoll-B treated 
sperm displayed a lower hyperactivation profile compared with other treatments. Overall, 
sperm motility parameters were positively correlated with blastocyst development across 
treatments except for group Old Bovipure.  
Addition of metabolic regulators to embryos originated from X-sorted sperm for 
IVF had reduced development from morula to blastocyst stages, and those reaching 
expanded blastocyst stages presented a smaller blastocoele when compared with 
untreated embryos. Blastomere counts were reduced in the MR treated embryos.  
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In conclusion, New Bovipure and Androcoll-B resulted in improved computerized 
motility parameters that were positively correlated with embryo development. Treatment 
with metabolic regulators PES and DNP in combination reduced overall blastocyst rates 
of X-sorted IVF embryos. Future studies are needed on the use of these metabolic 
regulators in combination with other additives to determine the gender-specific metabolic 
requirements of embryos. 
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INTRODUCTION 
 In several countries around the globe, dairy cattle reproduction relies mostly on 
ovulation synchronization and timed artificial insemination with frozen semen. In the 
bovine semen industry, entire ejaculates are typically processed with egg yolk or milk-
based extenders before freezing and storage. Usually, after semen is extended it contains 
a heterogeneous pool of spermatozoa including immature, abnormal and damaged sperm. 
In addition, any bacteria, cellular debris and leukocytes present may be a potential source 
of reactive oxygen species (ROS) and these are all detrimental factors, especially in an in 
vitro fertilization (IVF) context (Morrell, 2006). However, because acceptable post-thaw 
sperm performance assessed by computerized motility parameters can usually be 
attained, alternative sperm preparation methods such as sperm-density gradient 
centrifugation is not used in the semen industry. The current system for processing frozen 
semen stems from the fact that sire selection criteria include sperm survival and 
performance as contributions towards the sire’s overall fertility. Thus, sires with non-
viable sperm after freezing are more likely to be culled. Nonetheless, selection for sires 
that produce sperm with good freezability traits may have resulted inadvertently in 
selection of undesirable genetic traits that reduce fertility and is a current management 
issue in dairy cattle (Morrell and Rodriguez-Martinez, 2011; Soggiu et al., 2013).  
In human and endangered species with sub-optimal sperm populations, semen is 
highly valuable and discarding poor specimens is not an option. It has been reported in 
human IVF that processing the semen by density gradient centrifugation has resulted in 
increased conception rates (Morrell, 2006). Sperm density gradient separators, based on 
macromolecules suspended in a colloidal solution, are designed to sort motile 
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spermatozoa with normal morphology and intact DNA from the total sperm population, 
hence discriminating against immature and poor quality spermatozoa. During colloidal-
based sperm separation procedures, either by density gradient (DGC) or single layer 
centrifugation (SLC), viable sperm move to a point in the gradient that matches their own 
density i.e. iso-pynic point (Pertoft, 2000). Thus, by separating out good quality sperm 
from a sample, and eliminating ROS and bacteria, semen is better able to withstand the 
stress effects of cryopreservation procedures and  to have a longer survival time, thereby, 
to maximize potential for optimal fertilization (Morrell, 2000; Morrel and Rodriguez-
Martinez, 2011).  
 Among the many sperm separation methods that have been developed to improve 
sperm quality, DGC and swim-up are the most commonly used (Samardzija et al., 2006). 
Historically, Percoll DGC has been used as the method of choice to efficiently separate 
out sperm for human IVF procedures (Pertoft et al. 1978). Nevertheless, it has been 
reported in some studies (De Vos et al., 1997; Carrell et al., 1998) that Percoll has a toxic 
effect on human sperm, while not in others (Scott and Smith, 1997; Matás et al., 2003). 
Other studies indicated that there was a batch to batch variability in the degree of 
endotoxin levels present in the product and this led to the withdrawal of Percoll for 
human IVF by Pharmacia Biotech in 1996 (Classens et al., 1998; Moussett-Siméon et al., 
2004 ). Semen quality and related issues led researchers to explore alternative products 
for DGC that display minimal variability from batch to batch and reduce the risk of 
increasing endotoxin levels.  
 Alternative sperm fractionation products that are currently used for bovine species 
are Bovipure (Nidacon International AB, Göthenborg, Sweden) and Androcoll-B 
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(Swedish University of Agricultural Sciences, Uppsala, Sweden). Both products are 
silane-coated silica particles designed specifically to account for the density of viable 
sperm. In addition, according Nidacon’s recommendations, Bovipure can be used for 
both DGC and SLC. Further, Nidacon has recently improved their original formula 
Bovipure Bottom and Bovipure Top (Old Bovipure). The current version of Bovipure 
100 (New Bovipure) comes with a diluent. Androcoll-B is a ready-to-use solution with a 
proprietary formula owned by Dr. Morrell from the Swedish University of Agricultural 
Sciences, Uppsala, Sweden. A study by Samardzija et al. (2006) compared Bovipure 
DGC to the swim-up method and sperm recovered by DGC outperformed swim-up 
treated sperm based on motility and morphology. Although there were no differences at 
embryo cleavage stage, day-7 blastocyst rates were higher in embryos originating from 
the Bovipure DGC treatment. When used for SLC, Androcoll-B has proven not only to be 
equally efficient in terms of sperm recovery, motility and embryo development in vitro, 
but also to be more practical than DGC when working with large-volume ejaculates 
(Thys et al., 2009).   
 Currently in the cattle industry it is highly desirable to generate offspring of a 
specific gender. In the dairy industry, heifers are preferred over bull calves because of the 
needs for herd replacement and milk production. Increased use of sex-sorted semen has 
stimulated a new line of investigation among research groups. Further, the potential of 
obtaining female embryos in vitro exists and producing animals with known gender 
provides producers with more options for heifer replacement programs. However, in 
order for the technology of IVF coupled with sex-sorted semen to be efficiently 
exploited, it is mandatory to identify critical substrates and additives to improve embryo 
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production in vitro. There are several obstacles to overcome before this technique 
provides consistent results and becomes fully adopted in an in vitro embryo production 
system. The first obstacle is sire selection based on sperm sortability traits similar to 
sperm freezability traits (vide supra) since there was high variation among sires in an in 
vitro fertilization study (Cran et al. 1993). Another obstacle is that there seems to be a 
sperm-specific heparin concentration requirement for capacitation/hyperactivation during 
IVF that varies among sires (Lu and Seidel, 2004; Xu et al., 2009). A third important 
obstacle for sex-sorted semen is to find the minimal sperm concentration per number of 
oocytes, given that the recovery of sperm after centrifugation becomes substantially 
lower than when conventional semen is used. Although it has been reported by Xu et al. 
(2006) that as few as 600 sperm per oocyte are needed for optimal in vitro fertilization, 
due to the large variation among bulls, a reliable standard minimum sperm concentration 
needs to be established. Lastly gender-selected embryos may present different metabolic 
requirements. This is an important area for investigation as sex-sorted semen IVF may 
become the method of choice based on the fact that many oocytes can potentially be 
fertilized with one semen-straw rather than inseminating one cow. 
The first objective of the current study was to compare four different colloidal-
based sperm separators: Percoll (DGC), Old Bovipure (SLC), New Bovipure (SLC) and 
Androcoll-B (SLC) on sperm motility parameters and to evaluate the effects on embryo 
development. The second objective was to evaluate the effects of metabolic regulators 
(MR) on in vitro development of gender-selected embryos. 
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MATERIALS AND METHODS 
Chemicals and Reagents 
All chemicals and reagents were obtained from Sigma-Aldrich Co. (Saint Louis, MO, 
USA), unless otherwise indicated.  
Experimental design 
The effect of four colloidal-based sperm separators on sperm motion parameters and 
embryo development in vitro with conventional semen. 
In 3 replications, sperm analyses were performed soon after the last IVF well with 
oocytes was inseminated. One portion of each tube containing corresponding sperm from 
Percoll, Old Bovipure, New Bovipure and Androcoll-B treatments were analyzed by 
computer-assisted semen analysis (CASA). CASA uses 7 parameters to evaluate sperm 
motility.  
In vitro embryo production was carried out in five replicates, and four groups of 
cumulus oocyte complexes (COCs) were inseminated with sperm recovered by the 
aforementioned separator treatments. Early cleavage (36 hr post IVF) and late cleavage 
(48 hr post IVF) rates were measured to evaluate sperm treatment effects on embryo 
development. In addition, morula and blastocyst rates were measured at d 5 and d 8 post 
IVF to evaluate any effect from sperm treatment on further preimplantation embryo 
development. Blastomere nuclei staining under epifluorescent microscopy was used to 
determine total blastomere cell counts. A total of 851 COCs were used in this experiment. 
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The effects of metabolic regulators on development of in vitro produced embryos using 
X-sorted semen.  
In 4 replications, this trial measured the effects of the combined metabolic 
regulators, phenazine ethosulfate (PES) 0.3 μM and 3, 4—dinitrophenol (DNP) 10 μM, 
(Chapter Four) provided at morula stage on subsequent development of gender-selected 
female preimplantation embryos. Two groups were used: presumptive female-embryos 
originating from IVF with sex-sorted sperm were treated with or without MR at morula 
stage. In addition, embryos originating from IVF using conventional semen were used as 
internal control. Cleavage rates as well as morula and blastocyst rates were measured at 
days 2, 5 and 8 post IVF. Hoechst staining under epifluorescent microscopy was used to 
determine total blastomere cell counts. A total of 449 COCs were used in this experiment.  
Oocyte recovery and selection 
Bovine ovaries were collected at a nearby abattoir (120 km) and transported to the 
laboratory in prewarmed lactated Ringer’s solution at 30-35 °C. Cumulus oocyte-
complexes (COCs) from 2-8 mm follicles were aspirated with an 18G hypodermic needle 
attached to an aspiration pump unit adjusted to a flow of 22.5 ± 2.5 ml of H2O per 
minute. Follicular fluid supernatant was removed and the pellet containing COCs was 
transferred to a 15 ml tube where it was resuspended in holding medium and the contents 
were poured gently into a 100 mm Petri dish. Holding medium consisted of TCM-199 
Hank’s salts (Invitrogen, Grand Island, NY), 10% Fetal Calf Serum (FCS; Invitrogen), 25 
μg/ml of gentamicin, 0.2 mM Na-pyruvate, and heparin 5 μg/ml with a mOsm = 300 ± 1. 
Selection of COCs was based on morphological assessment as having several layers of 
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cumulus granulosa cells and oocytes with a homogenous cytoplasm. The entire process 
was performed within 5 hours, including transportation. 
In vitro pre-maturation 
Following the method of Albuz et al. (2010), selected COCs were pre-matured in 
holding medium supplemented with forskolin, an adenylate cyclase activator, and IBMX, 
a non-specific phosphodiesterase (PDE) inhibitor, at a final concentration of 100 μM and 
500 μM, respectively, in order to increase overall cAMP levels and to inhibit overall 
PDEs in both cumulus cells and oocytes. Millimolar stock concentrations of the 
chemicals were stored at -20 °C dissolved in dimethylsulphoxide (DMSO) and used fresh 
in each trial. In groups of about 40 COCs, pre-maturation treatment was carried out under 
atmospheric and humidified conditions at 38.5 °C for 2 hours. 
In vitro maturation 
Selected COCs were matured in groups of 40 ± 5 for 30 hours in 400 μL of TCM-
199 (Earle’s Salts) enriched with 10% FCS, 0.2 mM sodium pyruvate, 1 mM alanyl-
glutamine, 0.1 mM taurine, 0.1 mM cysteamine, 1 μg/ml estradiol, 85 mU/ml bovine 
follicle stimulating hormone (FSH, SIOUX Biochemical, Inc., Sioux Center, IA), 20 
μg/ml gentamicin, at pH 7.35 ± 0.02 and mOsm 300 ± 2 and covered with light mineral 
oil in a humidified atmosphere at 38.5 °C with 5% CO2 in air. In addition, based on 
Albuz et al. (2010), COCs were cultured during the entire maturation process with a type 
3-specific PDE inhibitor, cilostamide (20 μM; Biomol, Plymouth Meeting, PA, USA). 
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In vitro fertilization 
After a total of 30 hours, presumptive matured oocytes were transferred to a 
modified IVF medium (Fert-TALP; Parrish et al., 1988) supplemented with 0.5 mM 
fructose, 0.2 mM non-essential amino acids, 6 mg/ml BSA FFA Fraction V, 30 μM 
penicillamine, 15 μM hypotaurine, 1.5 μM epinephrine (PHE), 22 μg/ml heparin, 20 
μg/ml gentamicin, covered with light mineral oil in a humidified atmosphere at 38.5 °C 
with 5% CO2 in air for 18 hours (pH of 7.38 ± 0.01, mOsm 285 ± 1). Frozen semen 
straws (Genex, Ithaca NY, USA) from a single bull and from the same ejaculate were 
thawed at 37 °C for 30 seconds. Motile sperm were separated from cryoprotectant, non-
motile sperm, and debris by the following methods: Percoll® DGC (90% and 45%), Old 
Bovipure (SLC), New Bovipure (SLC; Nidacon International AB, Göthenborg, Sweden) 
and Androcoll-B (SLC; Swedish University of Agricultural Sciences, Uppsala, Sweden) 
at 300 x g for 20 min. Subsequently, sperm were washed twice in 5 ml of Boviwash 
(Nidacon International AB, Göthenborg, Sweden) and centrifuged at 300 x g for 5 min to 
remove each corresponding colloid. Finally, sperm were adjusted to a final concentration 
of 1.5 x 106 sperm/ml using Fert-TALP media and applied to the oocytes. For sex-sorted 
semen experiments 5 straws were thawed and sperm was recovered by using the New 
Bovipure SLC method. After all centrifugations, 2-3 million sperm were recovered and 
the final concentration of sperm was adjusted to 2 x 106 sperm/ml Fert-TALP media. 
In vitro embryo culture 
A modified synthetic oviductal fluid (SOF) sequential media  was used (20 μg/ml 
gentamicin, pH 7.4 ± 0.01, mOsm 275 ± 5, humidified atmosphere at 38.5 °C with 5% 
CO2, 7% O2, and 88% N2 [Holm et al., 1999]). After fertilization, putative zygotes were 
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denuded at maximum vortex speed for 120 seconds and transferred to a modified SOF 
(SOFearly) supplemented with 10 μM EDTA, 0.5 mM fructose, 0.4 % (w/v) BSA FFA 
Fraction V, 0.1 mM taurine, 10 ng/ml epidermal growth factor (EGF; BD Biosciences—
Discovery Labware, MA), without essential amino acids, and covered with light mineral 
oil for ~48 hours. Thereafter, cleavage rates were assessed and embryos were transferred 
to new droplets containing SOFmid1, with essential and non essential amino acids, 0.4 % 
(w/v) BSA FFA Fraction V, 1.0 mM glucose, 10 ng/ml EGF, 100 μM β mercapto ethanol 
(β-ME), 1 μM EDTA, and 1 ng/ml progesterone (P4) for ~48 hours. Embryos were 
transferred to fresh SOFmid2 droplets, which consists of SOFmid1 but supplemented with 
1.5 mM glucose, under the same conditions for another ~48 hours. Finally, d-7 embryos 
were transferred for the last ~ 24 hours of culture to SOFlate, which is SOF supplemented 
with 5% (v/v) FCS, 0.1 mM taurine, 10 ng/ml EGF, 1 ng/ml P4 and 2.0 mM glucose. 
Staining procedures 
Blastomere staining was based on Block et al. (2008). All incubations and 
washing steps were accomplished in 96-well dishes. Embryos were washed three times in 
PBS supplemented with 0.1% PVP (PBS/PVP) and then fixed in 4% paraformaldehyde 
PBS/PVP supplemented with 10 μg/ml Hoechst 33258 for 15 minutes at room 
temperature in the dark. Subsequently, embryos were washed 3 times in PBS/PVP 
solution to reduce non-specific binding. Embryos were mounted on slides with 2 etched 
10 mm diameter circles surrounded by white ceramic ink and covered with ProLong Gold 
antifade reagent (Invitrogen, Molecular probes). 
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Epifluorescent microscopy  
All slides were visualized using a microscope (Imager Z1; Carl Zeiss, Inc.) 
equipped with 20X 0.5 NA ECPlan Neofluar objective (Carl Zeiss, Inc.). Embryo 
samples were excited at 340 nm and the emitted wave length was 470 nm to visualize 
DAPI nuclear stain for the total cell count assessment. Images were captured with a 
cooled charged-coupled device camera (AxioCam MRm; Carl Zeiss, Inc.) and processed 
using AxioVision software (version 4.7.2; Carl Zeiss, Inc.).  
Assessment of sperm motion parameters by computer-assisted semen analysis (CASA) 
Immediately after IVF, 10 μL of sperm (3 replicates for each treatment) from the 
aliquots remaining were placed in a 2-chamber slide (Leja, The Netherlands) and sperm 
motion parameters were assessed by a Hamilton Thorne IVOS Sperm Analysis System 
(Hamilton Throne Inc., Beverly, MA). Smoothed path velocity (VAP), straight-line 
velocity (VSL), curvilinear velocity (VCL), linearity (LIN), amplitude of lateral head 
displacement (ALH), beat cross frequency (BCF), and straightness (STR) were 
determined. Instrument settings for the CASA analysis were as follows: frame rate 60 Hz; 
frames acquired 30, minimum contrast 70, minimum cell size 5 pixels, static VAP 
cutoff 5 μ/s, static VSL cutoff 15 μ/s, progressive VAP threshold 50 μ/s. Incomplete and 
crossed tracks were manually removed from data analysis. For each sample, at least 150 
sperm were assessed.  
Statistical analysis 
One-way analysis of variance (ANOVA) among treatments was performed using 
JMP version 10 (Statistical Discovery from SAS). If replicates were different over time, 
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we included replicate in our models as a random variable to control for the differences 
between and within experiments. If the main effect was significant, all means were 
compared using Tukey HSD. Comparison of means between the two sex-sorted semen 
groups was accomplished by Student’s t test. A probability of P <0.05 was considered 
statistically significant and P ≤ 0.1 was considered a trend. Proportional data not being 
normally distributed was arc-sine transformed and results are presented in the tables as 
back transformed data. Likewise, numerical data not being normally distributed was 
transformed to its natural logarithm.  
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RESULTS 
The effect of several colloidal-based sperm fractionation methods on sperm motion 
parameters and embryo development in vitro with conventional semen. 
We examined sperm motion parameters of the 4 colloidal-based sperm 
fractionation methods in this study to evaluate correlation of sperm motility performance 
with fertilization and embryo cleavage outcomes. Differences in sperm motion 
parameters among the 4 treatments (3 replicates each) in the study were observed and the 
results are summarized in Table 1. Sperm treated with New Bovipure and Androcoll-B 
tended to have higher velocity (VAP and VSL) and LIN motility values than those treated 
with Percoll or Old Bovipure. Sperm seemed to display one of the features of 
hyperactivation detected by high ALH (> 6.4 μM) even though the STR was above 90%. 
However, low ALH values were observed for Androcoll-B (P < 0.05) indicating that the 
sperm were not as hyperactive as the sperm from the other treatments. 
The effects of Percoll (DGC), Old Bovipure (SLC), New Bovipure (SLC) and 
Androcoll-B (SLC) on embryo development were assessed. There was a treatment effect 
on early cleavage rates (main effect: P = < 0.05) with Percoll being higher than 
Androcoll-B (Figure 1). There was a trend for Androcoll-B group to show higher late 
cleavage rates when compared to the other groups (P = 0.1; 13 % vs. ≤ 6 %). Total 
cleavage rates among groups followed a similar pattern as early cleavage rates (Percoll 
yielded higher cleavage rate than Androcoll-B group.  
 Analyses of embryo development during continued culture showed no significant 
differences among groups assessed at morula stage (5 days post-IVF) and values were 
above 80% (Table 2). However, significant differences were observed among blastocyst 
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rates (main effect: P < 0.05) where New Bovipure treatment yielded the highest rate and 
Old Bovipure yielded the lowest blastocyst development rate in this experiment.
 Blastomere counts were used to assess the developmental quality of expanded-
stage embryos and no significant differences were detected among treatments (Percoll = 
137 ± 5, Old Bovipure = 148 ± 6, New Bovipure = 149 ± 5 and Androcoll-B = 152 ± 7).  
The effects of metabolic regulators on development of in vitro produced embryos using 
X-sorted semen.  
 The effect of MR provided in culture at day 5 post IVF on embryo development 
and quality of gender-selected female embryos was evaluated (Table 3). Cleavage rates 
and subsequent development to morula stage at day 5 post IVF were not significantly 
different between MR-treated and non-treated female embryos. Blastocyst rates assessed 
at day 8 post IVF showed a trend for untreated embryos to display higher values than 
those treated with MR. When blastocyst rates were evaluated at specific stages of 
development, untreated embryos displayed higher expanded stage (30 % vs. 17 %) as 
well as hatched stage (5% vs. 0%) embryos when compared to MR treated female 
embryos (P < 0.05; Figure 2). The MR-treated female embryos showed reduced 
blastomere counts compared to untreated embryos (Figure 3; P < 0.05). All experiments 
were carried out in parallel with a quality control group using conventional semen and 
results fell within the historical range based on previous experiments (data not shown). 
Figure 4 presents pictures of embryo morphology for all groups. 
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DISCUSSION 
 Over the past 20 years the use of IVF has been gradually increasing and, 
presumably in the bovine species, this ART will become the method of choice, because it 
has several advantages over conventional breeding methods such as multiple ovulation 
embryo transfer (MOET) programs. For example, using ovum pick-up (OPU) coupled 
with IVF, oocytes can be harvested from cows as early as 30 days after calving that is 
substantially shorter than the waiting period for a cow to enter into a MOET program 
occurring somewhat later post-calving. Moreover, twice as many embryos can be 
produced in an OPU/IVF system compared with MOET programs. In addition, as the use 
of sex-sorted semen has the potential to yield better results when coupled with IVF 
technology, the capability to produce gender-selected embryos would open new 
opportunities both for research and business interests. In order for this to become a 
reality, it is necessary to optimize methods for the recovery of elite-quality sperm to 
improve current IVF outcomes. In addition, as embryos would be produced by gender it 
will be necessary to define not only sex-specific, but also stage-specific embryo 
metabolic requirements during culture.  
The first objective of the current study was to compare four different colloidal-
based sperm fractionation methods i.e. Percoll (DGC), Old Bovipure (SLC), New 
Bovipure (SLC) and Androcoll-B (SLC) on sperm motility parameters and to evaluate 
those effects on embryo development. Alternative colloidal-based sperm fractionation 
methods resulted in improved computerized motility parameters that were positively 
correlated with embryo development. In experiment 1, it was observed that sperm 
separated with New Bovipure and Androcoll-B showed higher velocity and linear 
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motility values as compared to the other treatments. Interestingly, sperm prepared using 
Androcoll-B showed the highest BCF and lowest ALH, values which indicates that this 
treatment yielded fewer hyperactive sperm.  
The second objective was to evaluate the effects of metabolic regulators (MR) on 
embryo development in vitro of gender-selected embryos. In experiment 2 following in 
vitro fertilization, Androcoll-B treated-sperm yielded embryos with significantly delayed 
cleavage rates at 36 hours post IVF, but this difference was no longer apparent during 
subsequent development to blastocysts. According to Alomar et al. (2008) early cleavage 
rates are associated with male embryos. Since blastocyst rates of the Androcoll-B treated 
group became similar to other groups, we might speculate that the pool of sperm that 
Androcoll-B separates may be skewed for X-bearing sperm i.e. female embryos. Also, 
given that Androcoll-B consistently resulted in sperm having an indication of low 
hyperactivity we may suggest that this motility variable may provide a marker for sex-
specific spermatozoa. Contrary to Jeulin et al. (1986), our results indicate that the low 
ALH was not necessarily correlated with poor embryo development. Although there were 
significant differences in terms of blastocyst rates by day 8 post IVF, the group with the 
lowest blastocyst yield was the Old Bovipure group. New Bovipure is a modified formula 
that improves in vitro fertilization outcomes (Dr. Niläng-Laessker, personal 
communication). Our results corroborate that the new formulation of this product yields 
higher embryo rates compared with the original formula.  
 Our results regarding the effects of metabolic regulators on gender-selected 
embryos were not expected. It is important to mention that we did not sex the embryos, 
but they were fertilized by X-sorted semen. Thus, presumptive female embryos treated 
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with MR showed reduced development from morula to blastocyst stages. Further, MR 
treated embryos had substantially reduced blastomere counts. Altogether, our results 
using MR, at least using the current dose, indicate that they do not improve embryo 
development. Although our previous findings (Chapter Four) indicate that MR yielded 
better embryo development rates, using MR for presumptive female embryos needs to be 
tested further. According to Garcia-Herreros et al. (2012) female embryos show a 
reduced expression for glycolytic gene markers compared to male embryos. In addition, 
Sturmey et al. (2010) have indicated that there is a nutrient specificity based on embryo 
gender, particularly for amino acids. Therefore, it is possible that providing the current 
dose of MR, we surpassed a threshold for glycolysis-related gene alteration resulting in 
delayed development and overall reduced quality of MR-treated female embryos. 
However, a very interesting observation was that, within the pool of reduced quality 
embryos, usually one or two embryos presented a similar quality compared with 
untreated female embryos or the internal quality control. We speculate that those 
embryos may have been male, given that current sperm sorting methods have 90 % 
efficiency. Future experiments using MR at the current concentration, but using only 
male embryos may corroborate this hypothesis. 
CONCLUSION 
Androcoll-B and New Bovipure sperm fractionation methods resulted in 
improved computerized motility parameters that were positively correlated with embryo 
development. Reduced ALH was inversely related to blastocyst development in the 
Androcoll-B treated group. Subtle differences among sperm separation methods were 
detected as early as 36 hr post fertilization and may reflect different iso-pynic points for 
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each product and separation of different sperm pools reflected not only in motility 
differences, but also in rates of development. Addition of two metabolic regulators, PES 
and DNP in combination, reduced overall blastocyst rates of presumptive female 
embryos. Future studies are needed on the use of these metabolic regulators in 
combination with other important media components to study the metabolic requirements 
of embryos by gender. 
ACKNOWLEDGMENTS 
The authors would like to thank the Consejo Nacional de Ciencia y Tecnología 
(CONACyT, México) as well as the Department of Animal Sicence (Cornell University) 
for providing financial support to VAA during his PhD program. Thanks to Cargill 
Wyalusing, PA for providing ovaries. We also appreciate the kind support from Genex 
Cooperative Inc., Ithaca, NY for donating semen. Thanks to Dr. Cohen’s lab for 
providing access to and advice for epifluorescence microscopy. Special thanks to 
Professor Jane Morrell from the Swedish University of Agricultural Sciences, Uppsala, 
Sweden for kindly providing Androcoll-B, and Dr. Anna Niläng-Laessker from Nidacon 
International AB, Mölndal, Sweden for kindly providing Bovipure products. 
  158 
REFERENCES 
Albuz, F. K., M. Sasseville, M. Lane, D. T. Armstrong, J. G. Thompson and R. B. 
Gilchrist. 2010. Simulated physiological oocyte maturation (SPOM): A novel in vitro 
maturation system that substantially improves embryo yield and pregnancy outcomes. 
Hum. Reprod. 25:2999-3011.  
Alomar, M., H. Tasiaux, S. Remacle, F. George, D. Paul and I. Donnay. 2008. Kinetics of 
fertilization and development, and sex ratio of bovine embryos produced using the semen 
of different bulls. Anim. Reprod. Sci. 107:48-61.  
Block, J., C. Wrenzycki, H. Niemann, D. Herrmann and P. J. Hansen. 2008. Effects of 
insulin-like growth factor-1 on cellular and molecular characteristics of bovine 
blastocysts produced in vitro. Mol. Reprod. Dev. 75:895-903.  
Carrell, D. T., P. H. Kuneck, C. M. Peterson, H. H. Hatasaka, K. P. Jones and B. F. 
Campbell. 1998a. A randomized, prospective analysis of five sperm preparation 
techniques before intrauterine insemination of husband sperm. Fertil. Steril. 69:122-126.  
Carrell, D. T., P. H. Kuneck, C. M. Peterson, H. H. Hatasaka, K. P. Jones and B. F. 
Campbell. 1998b. A randomized, prospective analysis of five sperm preparation 
techniques before intrauterine insemination of husband sperm. Fertil. Steril. 69:122-126.  
Claassens, O. E., R. Menkveld and K. L. Harrison. 1998. Evaluation of three substitutes 
for percoll in sperm isolation by density gradient centrifugation. Human Reproduction. 
13:3139-3143.  
Cran, D. G., L. A. Johnson, N. G. Miller, D. Cochrane and C. Polge. 1993. Production of 
bovine calves following separation of X- and Y-chromosome bearing sperm and in vitro 
fertilisation. Vet. Rec. 132:40-41.  
De Vos, A., Z. P. Nagy, H. Van de Velde, H. Joris, G. Bocken and A. Van Steirteghem. 
1997. Percoll gradient centrifugation can be omitted in sperm preparation for 
intracytoplasmic sperm injection. Human Reproduction. 12:1980-1984.  
Garcia-Herreros, M., I. M. Aparicio, D. Rath, T. Fair and P. and Lonergan. 2012. 
Differential glycolytic and glycogenogenic transduction pathways in male and female 
bovine embryos produced in vitro. Reprod. Fertil. Dev. 24, 344–352.  
Holm, P., P. J. Booth, M. H. Schmidt, T. Greve and H. Callesen. 1999. High bovine 
blastocyst development in a static in vitro production system using SOFaa medium 
supplemented with sodium citrate and myo-inositol with or without serum-proteins. 
Theriogenology. 52:683-700.  
  159 
Jeulin, C., D. Feneux, C. Serres, P. Jouannet, F. Guillet-Rosso, J. Belaisch-Allart, R. 
Frydman and J. Testart. 1986. Sperm factors related to failure of human in-vitro 
fertilization. Journal of Reproduction and Fertility. 76:735-744.  
Lu, K. H. and G. E. Seidel Jr. 2004. Effects of heparin and sperm concentration on 
cleavage and blastocyst development rates of bovine oocytes inseminated with flow 
cytometrically-sorted sperm. Theriogenology. 62:819-830.  
Matas, C., P. Coy, R. Romar, M. Marco, J. Gadea and S. Ruiz. 2003. Effect of sperm 
preparation method on in vitro fertilization in pigs. Reproduction. 125:133-141.  
Morrell, J. M. 2006. Update on semen technologies for animal breeding. Reprod. 
Domest. Anim. 41:63-67.  
Morrell, J. M. and H. Rodriguez-Martinez. 2010. Practical applications of sperm 
selection techniques as a tool for improving reproductive efficiency. Vet. Med. Int. 
2011:894767.  
Mousset-Siméon, N., N. Rives, L. Masse, F. Chevallier and B. Mace. 2004. Comparison 
of six density gradient media for selection of cryopreserved donor spermatozoa. J. 
Androl. 25:881-884.  
Parrish, J. J., J. Susko-Parrish, M. A. Winer and N. L. First. 1988. Capacitation of bovine 
sperm by heparin. Biol. Reprod. 38:1171-1180.  
Pertoft, H. 2000. Fractionation of cells and subcellular particles with percoll. J. Biochem. 
Biophys. Methods. 44:1-30.  
Pertoft, H., T. C. Laurent, T. Låås and L. Kågedal. 1978. Density gradients prepared from 
colloidal silica particles coated by polyvinylpyrrolidone (percoll). Anal. Biochem. 
88:271-282.  
Samardzija, M., M. Karadjole, I. Getz, Z. Makek, M. Cergolj and T. Dobranic. 2006. 
Effects of bovine spermatozoa preparation on embryonic development in vitro. Reprod. 
Biol. Endocrinol. 4:58.  
Scott, L. and S. Smith. 1997. Mouse in vitro fertilization, embryo development and 
viability, and human sperm motility in substances used for human sperm preparation for 
assisted reproduction. Fertil. Steril. 67:372-381.  
Soggiu, A., C. Piras, H. A. Hussein, M. De Canio, A. Gaviraghi, A. Galli, A. Urbani, L. 
Bonizzi and P. Roncada. 2013. Unravelling the bull fertility proteome. Mol. Biosyst. 
9:1188-1195.  
  160 
Sturmey, R. G., P. Bermejo-Alvarez, A. Gutierrez-Adan, D. Rizos, H. J. Leese and P. 
Lonergan. 2010. Amino acid metabolism of bovine blastocysts: A biomarker of sex and 
viability. Mol. Reprod. Dev. 77:285-296.  
Thys, M., L. Vandaele, J. M. Morrell, J. Mestach, A. Van Soom, M. Hoogewijs and H. 
Rodriguez-Martinez. 2009. In vitro fertilizing capacity of frozen-thawed bull 
spermatozoa selected by single-layer (glycidoxypropyltrimethoxysilane) silane-coated 
silica colloidal centrifugation. Reprod. Domest. Anim. 44:390-394.  
Xu, J., S. A. Chaubal and F. Du. 2009. Optimizing IVF with sexed sperm in cattle. 
Theriogenology. 71:39-47.  
Xu, J., Z. Guo, L. Su, T. L. Nedambale, J. Zhang, J. Schenk, J. F. Moreno, A. Dinnyés, 
W. Ji, X. C. Tian, X. Yang and F. Du. 2006. Developmental potential of vitrified holstein 
cattle embryos fertilized in vitro with sex-sorted sperm. J. Dairy Sci. 89:2510-2518.  
 
  
161 
TABLES 
Table 1. The effect of four colloidal-based sperm separators on sperm motion parameters using computer-assisted semen analysis 
(CASA). 
 
Treatments VAP* VSL* VCL ALH BCF STR LIN* 
Percoll  150.3 ± 14.9 144.7 ± 15.0 211.1 ± 15.5 6.4 ± 0.3a,b 42.4 ± 1.6 95.0 ± 1.7 68.0 ± 3.5 
Old Bovipure 145.7 ± 19.6 140.7 ± 18.5 207.4 ± 28.3 7.0 ± 0.3a 42.7 ± 2.3 96.3 ± 0.3 67.7 ± 0.3 
New Bovipure 162.7 ± 14.0 157.5 ± 14.0 229.4 ± 16.5 7.1 ± 0.3a 43.9 ± 1.1 96.0 ± 0.6 67.3 ± 2.0 
Androcoll-B 151.9 ± 12.0 148.3 ± 12.0 200.7 ± 13.3 5.7 ± 0.0b 43.5 ± 1.0 97.0 ± 0.6 73.0 ± 1.5 
 
Data are presented as Mean ± SEM. N=3. 
a, b Means ± SEM not sharing the same letter were significantly different (P< 0.05). 
*Asterisk indicates that there was a trend among groups (P ≤ 0.1) 
VAP: Smoothed Path Velocity (μm/s) 
VSL: Straight Line Velocity (μm/s)  
VCL: Track Velocity (μm/s)  
ALH: Amplitude of Lateral Head Displacement (μm)  
BCF: Beat Cross Frequency (Hz)  
STR: Straightness (ratio of VSL/VAP) 
LIN: Linearity (ratio of VSL/VCL)  
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Table 2. The effect of four colloidal-based sperm separators on embryo 
development using traditional frozen semen for IVF. 
 
Group Total oocytes  Cleavage %  Morula1% Blastocyst1 %  
Percoll 42.6 ± 0.9 87.7 ± 5.7a 88.1 ± 2.1 53.8 ± 4.1ab 
Old Bovipure 43.4 ± 1.5 81.5 ± 5.9ab 86.8 ± 2.2 43.9 ± 4.8b 
New Bovipure 42.0 ± 2.2 79.9 ± 6.8ab 87.6 ± 3.4 58.6 ± 2.2a 
Androcoll-B 42.2 ± 1.1 74.9 ± 3.6b 82.4 ± 6.4 54.3 ± 8.3ab 
 
Mean ± SEM from 5 replicates. Means within a column not sharing the same letter 
are significantly different (P < 0.05). 
1Morula and blastocyst rates were calculated as the percent of the total embryos 
cleaved to account for the treatment effects. 
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Table 3. The effect of metabolic regulators on development of gender-selected 
embryos after IVF. 
 
Groupa Total oocytes  Cleavage %  Morula1% Blastocyst1*%  
MR-SSS 41.3 ± 0.9 79.0 ± 2.0 85.7 ± 1.5 38.6 ± 2.9 
SSS 40.7 ± 0.7 80.3 ± 0.5 90.9 ± 4.7 41.7 ± 3.1 
 
aMR-SSS = Female embryos treated with metabolic regulators PES 0.3 μM and 
DNP 10 μM; SSS = Female embryos without metabolic regulator treatment. 
1Morula and blastocyst rates were calculated as the percent of the total embryos 
cleaved to account for fertilization effect. 
*There was a tendency for difference between groups (P = 0.06). 
Mean ± SEM from 4 replicates.  
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Figure 1. The effect of four colloidal-based sperm separators on in vitro 
embryo cleavage rates. 
Gray bars= Percoll; Purple bars= Old Bovipure; Blue bars= New 
Bovipure and Open bars= Androcoll-B. Mean ± SEM cleavage rates not 
sharing the same letter are significantly different among groups (P < 
0.05). Early cleavage was assessed 36 hours post in vitro fertilization 
and late cleavage along with the total cleavage rates were assessed by 48 
hours post in vitro fertilization. 
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Figure 2. The effect of metabolic regulators on embryo development of 
embryos from sexed semen. 
Blastocyst rates were assessed at day 8 post IVF. Open bars represent 
the gender-selected embryos treated with metabolic regulators PES 0.3 
μM + DNP 10 μM starting at day 5 post IVF. Blue bars represent 
gender-selected embryos without any treatment. Mean ± SEM blastocyst 
development rates marked with an asterisk were significantly different 
between groups. 
EB = Early blastocyst 
EX = Expanded blastocyst 
HT = Hatched blastocyst   
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Figure 3. The effect of metabolic regulators on blastomere counts of 
gender-selected embryos. 
Open bars represent the gender-selected embryos treated with metabolic 
regulators PES 0.3 μM + DNP 10 μM starting at day 5 post IVF (MR-
SSS). Blue bars represent gender-selected embryos without any 
treatment (SSS). A total of N= 86 Expanded-stage embryos were 
analyzed. Mean ± SEM blastomere counts marked with an asterisk were 
significantly different between groups. Counts were assessed at day 8 
post IVF.  
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Figure 4. The effect of metabolic regulators on embryo morphology. 
Panel a = gender-selected embryos treated with metabolic regulators PES 0.3 μM + DNP 10 μM starting at day 5 post 
IVF (MR-SSS). Arrow = Normal expanded blastocyst. Panel b represents gender-selected embryos without any 
treatment (SSS). Panel c represents control embryos fertilized using conventional semen.  
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INTEGRATED SUMMARY AND FURTHER REMARKS 
 Over the last three decades dairy cattle reproduction has been facing 
several metabolic challenges as a consequence of genetic selection for improved milk 
production traits. Assisted Reproduction Technologies (ART) have the potential to 
solve several issues the modern dairy cow is presenting to farmers. One example is the 
production of embryos in vitro. Embryo transfers using in vitro produced embryos 
(IVP) would have an advantage over conventional breeding methods since ovulation, 
fertilization and early embryonic stages would be bypassed, thereby enhancing the 
likelihood of embryo survival to implantation and hence improved pregnancy rates. 
However until today, based on several studies, we are not able to produce embryos of 
similar quality in vitro as compared to in vivo derived embryos. Better emulation of 
the molecular environment the embryos experience in transit to the uterus before 
implantation is necessary in order to produce good quality embryos in vitro. The 
overall objective of this dissertation was to study the effects of chemical additives that 
regulate metabolism at critical stages during this process and may enhance bovine 
embryo production in vitro.  
Metabolic processes occurring at preimplantation embryo stages and important 
updates during oocyte in vitro maturation along with respective sperm interactions 
during fertilization were reviewed in Chapter Two. As a result of the literature review, 
important new information led to further research with our in vitro embryo production 
system that resulted in a remarkable 10 % increase in blastocyst rates. Due to the 
strong impact polyunsaturated fatty acid CLA has as a nutraceutical within the public 
and research community, a systematic study was conducted on the effects of 
conjugated linoleic acid (CLA) isomers on embryos produced in vitro (Chapter 
Three). The addition of CLA to morula-stage embryos that were subsequently cultured 
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for 36 hrs before cryopreservation resulted in embryos with higher survival and better 
developmental rates post-thaw when compared to other groups. Enhancing glucose 
uptake and metabolism in morula stage embryos by providing an assisted metabolism 
approach is presented in Chapter Four. The addition of phenazine ethosulfate (PES) 
and 2, 4-dinitrophenol (DNP) resulted not only in higher embryo development and 
better quality, but also the embryos better withstood the cryopreservation procedures. 
Chapter Five presents the results of a study on the effect of four sperm separation 
products using different fractionation methods. Embryos derived from sperm 
fractionated by New Bovipure and Androcoll-B showed the highest blastocyst rates 
compared with Percoll and Old Bovipure groups. Surprisingly, we also found that 
addition of PES and DNP to presumptive female embryos from sex-sorted semen at 
morula stages resulted in delayed development and poor morphology as compared 
with untreated presumptive female embryos. More studies are necessary to define and 
optimize methods of culture for gender-selected embryos in vitro. Critical information 
has resulted from this dissertation that will certainly contribute to a better 
understanding and improvements in bovine IVP and to shape future research.  
The future demand for products from livestock species is predicted to increase 
dramatically as the current world population is predicted to rise from 7 to 9 billion 
people by the year 2050. For this reason it is necessary to define novel strategies for 
meeting those rather intimidating, demands. Assisted Reproduction Technologies have 
the potential to improve not only pregnancy rates, but also would provide producers 
opportunities to intelligently allocate types of genetics and gender specificity in order 
to improve their current management programs. As we may also reach the limits of the 
carrying capacity of our current production systems, genetically modified animals and 
plants are widely thought of as the potential solution. However, research on 
sustainable agriculture will play a fundamental role in how to integrate novel livestock 
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production systems with minimal environmental impact. The future of ART in light of 
genetically modified animals will involve a close relationship with the novel discipline 
area of nutrigenomics in order to exploit the full genetic potential of new genetic 
strains. 
 
 
 
